{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:47Z","timestamp":1792788047212,"version":"4.5.0"},"reference-count":310,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016887","name":"Motor Neurone Disease Research Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016887","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ross Maclean Fellowship"},{"name":"Brazil Family Program for Neurology"},{"DOI":"10.13039\/100014012","name":"FightMND","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008710","name":"Dementia Australia Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Increased phosphorylation of TDP-43 is a pathological hallmark of several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, the regulation and roles of TDP-43 phosphorylation remain incompletely understood. A variety of techniques have been utilized to understand TDP-43 phosphorylation, including kinase\/phosphatase manipulation, phosphomimic variants, and genetic, physical, or chemical inducement in a variety of cell cultures and animal models, and via analyses of post-mortem human tissues. These studies have produced conflicting results: suggesting incongruously that TDP-43 phosphorylation may either drive disease progression or serve a neuroprotective role. In this review, we explore the roles of regulators of TDP-43 phosphorylation including the putative TDP-43 kinases c-Abl, CDC7, CK1, CK2, IKK\u03b2, p38\u03b1\/MAPK14, MEK1, TTBK1, and TTBK2, and TDP-43 phosphatases PP1, PP2A, and PP2B, in disease. Building on recent studies, we also examine the consequences of TDP-43 phosphorylation on TDP-43 pathology, especially related to TDP-43 mislocalisation, liquid\u2013liquid phase separation, aggregation, and neurotoxicity. By comparing conflicting findings from various techniques and models, this review highlights both the discrepancies and unresolved aspects in the understanding of TDP-43 phosphorylation. We propose that the role of TDP-43 phosphorylation is site and context dependent, and includes regulation of liquid\u2013liquid phase separation, subcellular mislocalisation, and degradation. We further suggest that greater consideration of the normal functions of the regulators of TDP-43 phosphorylation that may be perturbed in disease is warranted. This synthesis aims to build towards a comprehensive understanding of the complex role of TDP-43 phosphorylation in the pathogenesis of neurodegeneration.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>\n                  <jats:p>TDP-43 is subject to phosphorylation by kinases and dephosphorylation by phosphatases, which variably impacts protein localisation, aggregation, and neurotoxicity in neurodegenerative diseases.<\/jats:p>","DOI":"10.1186\/s13024-025-00839-8","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T12:24:07Z","timestamp":1746707047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration"],"prefix":"10.1186","volume":"20","author":[{"given":"Elise A.","family":"Kellett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adekunle T.","family":"Bademosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7954-5801","authenticated-orcid":false,"given":"Adam K.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"issue":"3","key":"839_CR1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"S-C Ling","year":"2013","unstructured":"Ling S-C, Polymenidou M, Cleveland DW. Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis. Neuron. 2013;79(3):416\u201338.","journal-title":"Neuron"},{"issue":"6","key":"839_CR2","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142(6):1503\u201327.","journal-title":"Brain"},{"key":"839_CR3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.brainres.2007.09.048","volume":"1184","author":"S Higashi","year":"2007","unstructured":"Higashi S, Iseki E, Yamamoto R, Minegishi M, Hino H, Fujisawa K, et al. Concurrence of TDP-43, tau and \u03b1-synuclein pathology in brains of Alzheimer\u2019s disease and dementia with Lewy bodies. Brain Res. 2007;1184:284\u201394.","journal-title":"Brain Res"},{"issue":"3","key":"839_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","volume":"114","author":"H Nakashima-Yasuda","year":"2007","unstructured":"Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 2007;114(3):221\u20139.","journal-title":"Acta Neuropathol"},{"issue":"19 Part 2","key":"839_CR5","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1212\/01.wnl.0000304041.09418.b1","volume":"70","author":"KA Josephs","year":"2008","unstructured":"Josephs KA, Whitwell JL, Knopman DS, Hu WT, Stroh DA, Baker M, et al. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurol. 2008;70(19 Part 2):1850\u20137.","journal-title":"Neurol."},{"issue":"2","key":"839_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00401-008-0408-9","volume":"116","author":"W-L Lin","year":"2008","unstructured":"Lin W-L, Dickson DW. Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases. Acta Neuropathol. 2008;116(2):205\u201313.","journal-title":"Acta Neuropathol"},{"issue":"12","key":"839_CR7","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/NEN.0b013e31818e8951","volume":"67","author":"C Schwab","year":"2008","unstructured":"Schwab C, Arai T, Hasegawa M, Yu S, McGeer PL. Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. J Neuropathol Exp Neurol. 2008;67(12):1159\u201365.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"839_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00401-008-0480-1","volume":"117","author":"T Arai","year":"2009","unstructured":"Arai T, Mackenzie IR, Hasegawa M, Nonoka T, Niizato K, Tsuchiya K, et al. Phosphorylated TDP-43 in Alzheimer\u2019s disease and dementia with Lewy bodies. Acta Neuropathol. 2009;117(2):125\u201336.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"839_CR9","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/brain\/awr053","volume":"134","author":"PT Nelson","year":"2011","unstructured":"Nelson PT, Schmitt FA, Lin Y, Abner EL, Jicha GA, Patel E, et al. Hippocampal sclerosis in advanced age: clinical and pathological features. Brain. 2011;134(5):1506\u201318.","journal-title":"Brain"},{"issue":"3","key":"839_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00401-013-1211-9","volume":"127","author":"KA Josephs","year":"2014","unstructured":"Josephs KA, Murray ME, Whitwell JL, Parisi JE, Petrucelli L, Jack CR, et al. Staging TDP-43 pathology in Alzheimer\u2019s disease. Acta Neuropathol. 2014;127(3):441\u201350.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"839_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ana.21425","volume":"64","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 2008;64(1):60\u201370.","journal-title":"Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society"},{"issue":"19","key":"839_CR12","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.febslet.2008.07.027","volume":"582","author":"Y Inukai","year":"2008","unstructured":"Inukai Y, Nonaka T, Arai T, Yoshida M, Hashizume Y, Beach TG, et al. Abnormal phosphorylation of Ser409\/410 of TDP-43 in FTLD-U and ALS. FEBS Lett. 2008;582(19):2899\u2013904.","journal-title":"FEBS Lett"},{"issue":"2","key":"839_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-008-0477-9","volume":"117","author":"M Neumann","year":"2009","unstructured":"Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, Xu Y, et al. Phosphorylation of S409\/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009;117(2):137\u201349.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"839_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/ana.23870","volume":"74","author":"NF Liachko","year":"2013","unstructured":"Liachko NF, McMillan PJ, Guthrie CR, Bird TD, Leverenz JB, Kraemer BC. CDC7 inhibition blocks pathological TDP-43 phosphorylation and neurodegeneration. Ann Neurol. 2013;74(1):39\u201352.","journal-title":"Ann Neurol"},{"issue":"12","key":"839_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004803","volume":"10","author":"NF Liachko","year":"2014","unstructured":"Liachko NF, McMillan PJ, Strovas TJ, Loomis E, Greenup L, Murrell JR, et al. The tau tubulin kinases TTBK1\/2 promote accumulation of pathological TDP-43. PLoS Genet. 2014;10(12): e1004803.","journal-title":"PLoS Genet"},{"issue":"4","key":"839_CR16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/hmg\/ddt498","volume":"23","author":"DK Choksi","year":"2014","unstructured":"Choksi DK, Roy B, Chatterjee S, Yusuff T, Bakhoum MF, Sengupta U, et al. TDP-43 Phosphorylation by casein kinase I\u03b5 promotes oligomerization and enhances toxicity in vivo. Hum Mol Genet. 2014;23(4):1025\u201335.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"839_CR17","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1021\/jm500065f","volume":"57","author":"IG Salado","year":"2014","unstructured":"Salado IG, Redondo M, Bello ML, Perez CN, Liachko NF, Kraemer BC, et al. Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis. J Med Chem. 2014;57(6):2755\u201372.","journal-title":"J Med Chem."},{"issue":"11","key":"839_CR18","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1074\/jbc.M115.695379","volume":"291","author":"T Nonaka","year":"2016","unstructured":"Nonaka T, Suzuki G, Tanaka Y, Kametani F, Hirai S, Okado H, et al. Phosphorylation of TAR DNA-binding protein of 43 kDa (TDP-43) by truncated casein kinase 1\u03b4 triggers mislocalization and accumulation of TDP-43. J Biol Chem. 2016;291(11):5473\u201383.","journal-title":"J Biol Chem"},{"issue":"1","key":"839_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13024-016-0102-7","volume":"11","author":"C Alquezar","year":"2016","unstructured":"Alquezar C, Salado IG, de la Encarnaci\u00f3n A, P\u00e9rez DI, Moreno F, Gil C, et al. Targeting TDP-43 phosphorylation by Casein Kinase-1\u03b4 inhibitors: a novel strategy for the treatment of frontotemporal dementia. Mol Neurodegener. 2016;11(1):36.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"839_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00401-018-1870-7","volume":"136","author":"F Krach","year":"2018","unstructured":"Krach F, Batra R, Wheeler EC, Vu AQ, Wang R, Hutt K, et al. Transcriptome\u2013pathology correlation identifies interplay between TDP-43 and the expression of its kinase CK1E in sporadic ALS. Acta Neuropathol. 2018;136(3):405\u201323.","journal-title":"Acta Neuropathol"},{"key":"839_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fncel.2018.00079","volume":"12","author":"L Sun","year":"2018","unstructured":"Sun L, Zhang K, Zhai W, Li H, Shen H, Yu Z, et al. TAR DNA binding protein-43 loss of function induced by phosphorylation at S409\/410 blocks autophagic flux and participates in secondary brain injury after intracerebral hemorrhage. Front Cell Neurosci. 2018;12:79.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"839_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-018-0237-9","volume":"13","author":"LM Taylor","year":"2018","unstructured":"Taylor LM, McMillan PJ, Liachko NF, Strovas TJ, Ghetti B, Bird TD, et al. Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration. Mol Neurodegener. 2018;13(1):1\u201314.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"839_CR23","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1007\/s12035-018-1249-8","volume":"56","author":"D Posa","year":"2019","unstructured":"Posa D, Mart\u00ednez-Gonz\u00e1lez L, Bartolom\u00e9 F, Nagaraj S, Porras G, Mart\u00ednez A, et al. Recapitulation of Pathological TDP-43 Features in Immortalized Lymphocytes from Sporadic ALS Patients. Mol Neurobiol. 2019;56(4):2424\u201332.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"839_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-61265-y","volume":"10","author":"L Mart\u00ednez-Gonz\u00e1lez","year":"2020","unstructured":"Mart\u00ednez-Gonz\u00e1lez L, Rodr\u00edguez-Cueto C, Cabezudo D, Bartolom\u00e9 F, Andr\u00e9s-Benito P, Ferrer I, et al. Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1\u03b4 kinase inhibitor treatment. Sci Rep. 2020;10(1):1\u201312.","journal-title":"Sci Rep"},{"key":"839_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105548","volume":"161","author":"Y Tian","year":"2021","unstructured":"Tian Y, Wang Y, Jablonski AM, Hu Y, Sugam JA, Koglin M, et al. Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology. Neurobiol Dis. 2021;161: 105548.","journal-title":"Neurobiol Dis"},{"key":"839_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112968","volume":"210","author":"E Rojas-Prats","year":"2021","unstructured":"Rojas-Prats E, Martinez-Gonzalez L, Gonzalo-Consuegra C, Liachko NF, Perez C, Ram\u00edrez D, et al. Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis. Eur J Med Chem. 2021;210: 112968.","journal-title":"Eur J Med Chem"},{"issue":"3","key":"839_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/jnc.15118","volume":"156","author":"G Vaca","year":"2021","unstructured":"Vaca G, Martinez-Gonzalez L, Fernandez A, Rojas-Prats E, Porras G, Cuevas EP, et al. Therapeutic potential of novel Cell Division Cycle Kinase 7 inhibitors on TDP-43-related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). J Neurochem. 2021;156(3):379\u201390.","journal-title":"J Neurochem"},{"issue":"1","key":"839_CR28","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202103033","volume":"221","author":"X Deng","year":"2021","unstructured":"Deng X, Sun X, Yue W, Duan Y, Hu R, Zhang K, et al. CHMP2B regulates TDP-43 phosphorylation and cytotoxicity independent of autophagy via CK1. J Cell Biol. 2021;221(1): e202103033.","journal-title":"J Cell Biol"},{"issue":"24","key":"839_CR29","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.3390\/cells11243972","volume":"11","author":"S Lee","year":"2022","unstructured":"Lee S, Ryu HG, Kweon SH, Kim H, Park H, Lee K-H, et al. c-Abl Regulates the Pathological Deposition of TDP-43 via Tyrosine 43 Phosphorylation. Cells. 2022;11(24):3972.","journal-title":"Cells"},{"key":"839_CR30","doi-asserted-by":"crossref","unstructured":"Nozal V, Mart\u00ednez-Gonz\u00e1lez L, Gomez-Almeria M, Gonzalo-Consuegra C, Santana P, Chaikuad A, et al. TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy. J Med Chem. 2022;65(2).","DOI":"10.1021\/acs.jmedchem.1c01942"},{"issue":"8","key":"839_CR31","doi-asserted-by":"publisher","first-page":"e23075","DOI":"10.1371\/journal.pone.0023075","volume":"6","author":"HY Li","year":"2011","unstructured":"Li HY, Yeh PA, Chiu HC, Tang CY, Tu BPH. Hyperphosphorylation as a defense mechanism to reduce TDP-43 aggregation. PloS one. 2011;6(8):e23075.","journal-title":"PloS one."},{"issue":"12","key":"839_CR32","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1074\/jbc.M116.753913","volume":"292","author":"W Li","year":"2017","unstructured":"Li W, Reeb AN, Lin B, Subramanian P, Fey EE, Knoverek CR, et al. Heat shock-induced phosphorylation of TAR DNA-binding protein 43 (TDP-43) by MAPK\/ERK kinase regulates TDP-43 function. J Biol Chem. 2017;292(12):5089\u2013100.","journal-title":"J Biol Chem"},{"issue":"5","key":"839_CR33","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201797452","volume":"37","author":"A Wang","year":"2018","unstructured":"Wang A, Conicella AE, Schmidt HB, Martin EW, Rhoads SN, Reeb AN, et al. A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing. EMBO J. 2018;37(5): e97452.","journal-title":"EMBO J"},{"key":"839_CR34","doi-asserted-by":"crossref","unstructured":"Gruijs da Silva LA, Simonetti F, Hutten S, Riemenschneider H, Sternburg EL, Pietrek LM, et al. Disease-linked TDP-43 hyperphosphorylation suppresses TDP-43 condensation and aggregation. The EMBO Journal. 2022;41(8):e108443.","DOI":"10.15252\/embj.2021108443"},{"issue":"2","key":"839_CR35","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202302048","volume":"223","author":"Y Iguchi","year":"2024","unstructured":"Iguchi Y, Takahashi Y, Li J, Araki K, Amakusa Y, Kawakami Y, et al. I\u03baB kinase phosphorylates cytoplasmic TDP-43 and promotes its proteasome degradation. J Cell Biol. 2024;223(2): e202302048.","journal-title":"J Cell Biol"},{"key":"839_CR36","doi-asserted-by":"crossref","unstructured":"Keating SS, San Gil R, Swanson ME, Scotter EL, Walker AK. TDP-43 pathology: from noxious assembly to therapeutic removal. Progress in Neurobiology. 2022;211:102229.","DOI":"10.1016\/j.pneurobio.2022.102229"},{"issue":"2","key":"839_CR37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/emboj.2010.310","volume":"30","author":"YM Ayala","year":"2011","unstructured":"Ayala YM, De Conti L, Avenda\u00f1o-V\u00e1zquez SE, Dhir A, Romano M, D\u2019ambrogio A, et al. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 2011;30(2):277\u201388.","journal-title":"EMBO J"},{"issue":"7","key":"839_CR38","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1093\/nar\/gkt1407","volume":"42","author":"P-H Kuo","year":"2014","unstructured":"Kuo P-H, Chiang C-H, Wang Y-T, Doudeva LG, Yuan HS. The crystal structure of TDP-43 RRM1-DNA complex reveals the specific recognition for UG-and TG-rich nucleic acids. Nucleic Acids Res. 2014;42(7):4712\u201322.","journal-title":"Nucleic Acids Res"},{"issue":"R1","key":"839_CR39","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1093\/hmg\/ddq137","volume":"19","author":"C Lagier-Tourenne","year":"2010","unstructured":"Lagier-Tourenne C, Polymenidou M, Cleveland DW. TDP-43 and FUS\/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet. 2010;19(R1):R46\u201364.","journal-title":"Hum Mol Genet"},{"issue":"7899","key":"839_CR40","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41586-022-04424-7","volume":"603","author":"XR Ma","year":"2022","unstructured":"Ma XR, Prudencio M, Koike Y, Vatsavayai SC, Kim G, Harbinski F, et al. TDP-43 represses cryptic exon inclusion in the FTD\u2013ALS gene UNC13A. Nature. 2022;603(7899):124\u201330.","journal-title":"Nature"},{"key":"839_CR41","doi-asserted-by":"crossref","unstructured":"Melamed Ze, L\u00f3pez-Erauskin J, Baughn MW, Zhang O, Drenner K, Sun Y, et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nature neuroscience. 2019;22(2):180\u201390.","DOI":"10.1038\/s41593-018-0293-z"},{"key":"839_CR42","doi-asserted-by":"crossref","unstructured":"Klim JR, Williams LA, Limone F, Guerra San Juan I, Davis-Dusenbery BN, Mordes DA, et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nature neuroscience. 2019;22(2):167\u201379.","DOI":"10.1038\/s41593-018-0300-4"},{"issue":"7899","key":"839_CR43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-022-04436-3","volume":"603","author":"A-L Brown","year":"2022","unstructured":"Brown A-L, Wilkins OG, Keuss MJ, Hill SE, Zanovello M, Lee WC, et al. TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature. 2022;603(7899):131\u20137.","journal-title":"Nature"},{"issue":"9","key":"839_CR44","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.tig.2022.06.004","volume":"38","author":"AT Bademosi","year":"2022","unstructured":"Bademosi AT, Walker AK. Cryptic inclusions UNCover losses driving neurodegeneration. Trends Genet. 2022;38(9):889\u201391.","journal-title":"Trends Genet"},{"issue":"11","key":"839_CR45","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1093\/brain\/awab217","volume":"144","author":"H Sidib\u00e9","year":"2021","unstructured":"Sidib\u00e9 H, Khalfallah Y, Xiao S, G\u00f3mez NB, Fakim H, Tank EM, et al. TDP-43 stabilizes G3BP1 mRNA: relevance to amyotrophic lateral sclerosis\/frontotemporal dementia. Brain. 2021;144(11):3461\u201376.","journal-title":"Brain"},{"issue":"2","key":"839_CR46","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1074\/jbc.M110.190884","volume":"286","author":"CF Sephton","year":"2011","unstructured":"Sephton CF, Cenik C, Kucukural A, Dammer EB, Cenik B, Han Y, et al. Identification of Neuronal RNA Targets of TDP-43-containing Ribonucleoprotein Complexes*\u2666. J Biol Chem. 2011;286(2):1204\u201315.","journal-title":"J Biol Chem"},{"issue":"5","key":"839_CR47","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1128\/MCB.01279-10","volume":"31","author":"CM Dewey","year":"2011","unstructured":"Dewey CM, Cenik B, Sephton CF, Dries DR, Mayer P III, Good SK, et al. TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol Cell Biol. 2011;31(5):1098\u2013108.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"839_CR48","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/emboj.2011.471","volume":"31","author":"TJ Cohen","year":"2012","unstructured":"Cohen TJ, Hwang AW, Unger T, Trojanowski JQ, Lee VM. Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking. EMBO J. 2012;31(5):1241\u201352.","journal-title":"EMBO J"},{"issue":"1","key":"839_CR49","doi-asserted-by":"publisher","first-page":"7551","DOI":"10.1038\/s41598-018-25767-0","volume":"8","author":"Y Khalfallah","year":"2018","unstructured":"Khalfallah Y, Kuta R, Grasmuck C, Prat A, Durham HD, Vande VC. TDP-43 regulation of stress granule dynamics in neurodegenerative disease-relevant cell types. Sci Rep. 2018;8(1):7551.","journal-title":"Sci Rep"},{"key":"839_CR50","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fnmol.2017.00170","volume":"10","author":"M Budini","year":"2017","unstructured":"Budini M, Buratti E, Morselli E, Criollo A. Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72. Front Mol Neurosci. 2017;10:170.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"839_CR51","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1038\/ncomms6845","volume":"6","author":"TJ Cohen","year":"2015","unstructured":"Cohen TJ, Hwang AW, Restrepo CR, Yuan C-X, Trojanowski JQ, Lee VM. An acetylation switch controls TDP-43 function and aggregation propensity. Nat Commun. 2015;6(1):5845.","journal-title":"Nat Commun"},{"key":"839_CR52","doi-asserted-by":"crossref","unstructured":"Cracco L, Doud EH, Hallinan GI, Garringer HJ, Jacobsen MH, Richardson R, et al. Distinguishing post-translational modifications in dominantly inherited FTD: FTLD-TDP Type A (GRN) versus Type B (C9orf72). Neuropathol Appl Neurobiol. 2022:e12836.","DOI":"10.1111\/nan.12836"},{"issue":"4","key":"839_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008495","volume":"16","author":"CM Burke","year":"2020","unstructured":"Burke CM, Walsh DJ, Mark KM, Deleault NR, Nishina KA, Agrimi U, et al. Cofactor and glycosylation preferences for in vitro prion conversion are predominantly determined by strain conformation. PLoS Pathog. 2020;16(4): e1008495.","journal-title":"PLoS Pathog"},{"issue":"1","key":"839_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep43295","volume":"7","author":"P Aguilar-Calvo","year":"2017","unstructured":"Aguilar-Calvo P, Xiao X, Bett C, Era\u00f1a H, Soldau K, Castilla J, et al. Post-translational modifications in PrP expand the conformational diversity of prions in vivo. Sci Rep. 2017;7(1):1\u201315.","journal-title":"Sci Rep"},{"issue":"5796","key":"839_CR55","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130\u20133.","journal-title":"Science"},{"issue":"1","key":"839_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115205","volume":"44","author":"M Aikio","year":"2025","unstructured":"Aikio M, Odeh HM, Wobst HJ, Lee BL, Chan \u00da, Mauna JC, et al. Opposing roles of p38\u03b1-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathy. Cell Rep. 2025;44(1): 115205.","journal-title":"Cell Rep"},{"key":"839_CR57","doi-asserted-by":"crossref","unstructured":"Saunders CR, Rocha-Rangel PV, Desai R, Quadri Z, Liu H, Hunt Jr JB, et al. Citrullination of TDP-43 is a key post-translation modification associated with structural and functional changes and progressive pathology in TDP-43 mouse models and human proteinopathies. bioRxiv. 2025:2025.02. 28.639952.","DOI":"10.1101\/2025.02.28.639952"},{"issue":"Pt 22","key":"839_CR58","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1242\/jcs.038950","volume":"121","author":"YM Ayala","year":"2008","unstructured":"Ayala YM, Zago P, D\u2019Ambrogio A, Xu YF, Petrucelli L, Buratti E, et al. Structural determinants of the cellular localization and shuttling of TDP-43. J Cell Sci. 2008;121(Pt 22):3778\u201385.","journal-title":"J Cell Sci"},{"issue":"3","key":"839_CR59","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.neuron.2013.12.018","volume":"81","author":"NH Alami","year":"2014","unstructured":"Alami NH, Smith RB, Carrasco MA, Williams LA, Winborn CS, Han SS, et al. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron. 2014;81(3):536\u201343.","journal-title":"Neuron"},{"key":"839_CR60","doi-asserted-by":"crossref","unstructured":"Chu J-F, Majumder P, Chatterjee B, Huang S-L, Shen C-KJ. TDP-43 regulates coupled dendritic mRNA transport-translation processes in co-operation with FMRP and Staufen1. Cell reports. 2019;29(10):3118\u201333. e6.","DOI":"10.1016\/j.celrep.2019.10.061"},{"issue":"1","key":"839_CR61","doi-asserted-by":"publisher","first-page":"7083","DOI":"10.1038\/s41598-018-25008-4","volume":"8","author":"ES Pinarbasi","year":"2018","unstructured":"Pinarbasi ES, Ca\u011fatay T, Fung HYJ, Li YC, Chook YM, Thomas PJ. Active nuclear import and passive nuclear export are the primary determinants of TDP-43 localization. Sci Rep. 2018;8(1):7083.","journal-title":"Sci Rep"},{"issue":"13","key":"839_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111007","volume":"39","author":"SG Doll","year":"2022","unstructured":"Doll SG, Meshkin H, Bryer AJ, Li F, Ko Y-H, Lokareddy RK, et al. Recognition of the TDP-43 nuclear localization signal by importin \u03b11\/\u03b2. Cell Rep. 2022;39(13): 111007.","journal-title":"Cell Rep"},{"issue":"8","key":"839_CR63","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nm.4130","volume":"22","author":"W Wang","year":"2016","unstructured":"Wang W, Wang L, Lu J, Siedlak SL, Fujioka H, Liang J, et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat Med. 2016;22(8):869\u201378.","journal-title":"Nat Med"},{"issue":"23","key":"839_CR64","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1093\/hmg\/ddt319","volume":"22","author":"W Wang","year":"2013","unstructured":"Wang W, Li L, Lin W-L, Dickson DW, Petrucelli L, Zhang T, et al. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum Mol Genet. 2013;22(23):4706\u201319.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"839_CR65","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ymthe.2016.10.013","volume":"25","author":"W Wang","year":"2017","unstructured":"Wang W, Arakawa H, Wang L, Okolo O, Siedlak SL, Jiang Y, et al. Motor-coordinative and cognitive dysfunction caused by mutant TDP-43 could be reversed by inhibiting its mitochondrial localization. Mol Ther. 2017;25(1):127\u201339.","journal-title":"Mol Ther"},{"key":"839_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-2660(09)66001-6","volume":"66","author":"E Buratti","year":"2009","unstructured":"Buratti E, Baralle FE. The molecular links between TDP-43 dysfunction and neurodegeneration. Adv Genet. 2009;66:1\u201334.","journal-title":"Adv Genet"},{"key":"839_CR67","doi-asserted-by":"crossref","unstructured":"Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, et al. Accurate structure prediction of biomolecular interactions with AlphaFold\u20093. Nature. 2024;630.","DOI":"10.1038\/s41586-024-07487-w"},{"issue":"7","key":"839_CR68","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/cbic.201200093","volume":"13","author":"N Rezaei-Ghaleh","year":"2012","unstructured":"Rezaei-Ghaleh N, Blackledge M, Zweckstetter M. Intrinsically disordered proteins: from sequence and conformational properties toward drug discovery. ChemBioChem. 2012;13(7):930\u201350.","journal-title":"ChemBioChem"},{"issue":"5870","key":"839_CR69","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.1154584","volume":"319","author":"J Sreedharan","year":"2008","unstructured":"Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319(5870):1668\u201372.","journal-title":"Science"},{"issue":"2","key":"839_CR70","doi-asserted-by":"publisher","first-page":"R156","DOI":"10.1093\/hmg\/ddp303","volume":"18","author":"GS Pesiridis","year":"2009","unstructured":"Pesiridis GS, Lee VMY, Trojanowski JQ. Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Human Mole Gene. 2009;18(2):R156\u201362.","journal-title":"Human Mole Gene"},{"issue":"5","key":"839_CR71","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/ng.132","volume":"40","author":"E Kabashi","year":"2008","unstructured":"Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Velde CV, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008;40(5):572\u20134.","journal-title":"Nat Genet"},{"key":"839_CR72","doi-asserted-by":"crossref","unstructured":"Chang C-k, Wu T-H, Wu C-Y, Chiang M-h, Toh EK-W, Hsu Y-C, et al. The N-terminus of TDP-43 promotes its oligomerization and enhances DNA binding affinity. Biochemical and biophysical research communications. 2012;425(2):219\u201324.","DOI":"10.1016\/j.bbrc.2012.07.071"},{"key":"839_CR73","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brainres.2016.04.069","volume":"1647","author":"H Sasaguri","year":"2016","unstructured":"Sasaguri H, Chew J, Xu Y-F, Gendron TF, Garrett A, Lee CW, et al. The extreme N-terminus of TDP-43 mediates the cytoplasmic aggregation of TDP-43 and associated toxicity in vivo. Brain Res. 2016;1647:57\u201364.","journal-title":"Brain Res"},{"issue":"17","key":"839_CR74","doi-asserted-by":"publisher","first-page":"6259","DOI":"10.3390\/ijms21176259","volume":"21","author":"M Vivoli-Vega","year":"2020","unstructured":"Vivoli-Vega M, Guri P, Chiti F, Bemporad F. Insight into the folding and dimerization mechanisms of the N-terminal domain from human TDP-43. Int J Mol Sci. 2020;21(17):6259.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"839_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep23281","volume":"6","author":"F Kametani","year":"2016","unstructured":"Kametani F, Obi T, Shishido T, Akatsu H, Murayama S, Saito Y, et al. Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains. Sci Rep. 2016;6(1):1\u201315.","journal-title":"Sci Rep"},{"issue":"1","key":"839_CR76","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41593-018-0294-y","volume":"22","author":"F Laferri\u00e8re","year":"2019","unstructured":"Laferri\u00e8re F, Maniecka Z, P\u00e9rez-Berlanga M, Hruska-Plochan M, Gilhespy L, Hock E-M, et al. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. Nat Neurosci. 2019;22(1):65\u201377.","journal-title":"Nat Neurosci"},{"issue":"1","key":"839_CR77","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-020-02242-7","volume":"141","author":"M Neumann","year":"2021","unstructured":"Neumann M, Frick P, Paron F, Kosten J, Buratti E, Mackenzie IR. Correction to: Antibody against TDP-43 phosphorylated at serine 369 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes. Acta Neuropathol. 2021;141(1):137.","journal-title":"Acta Neuropathol"},{"issue":"10047","key":"839_CR78","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(16)00737-6","volume":"388","author":"JR Burrell","year":"2016","unstructured":"Burrell JR, Halliday GM, Kril JJ, Ittner LM, G\u00f6tz J, Kiernan MC, et al. The frontotemporal dementia-motor neuron disease continuum. The Lancet. 2016;388(10047):919\u201331.","journal-title":"The Lancet"},{"issue":"8","key":"839_CR79","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024117","volume":"7","author":"LI Grad","year":"2017","unstructured":"Grad LI, Rouleau GA, Ravits J, Cashman NR. Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harb Perspect Med. 2017;7(8): a024117.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"839_CR80","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/cercor\/bhr004","volume":"22","author":"E-J Kim","year":"2012","unstructured":"Kim E-J, Sidhu M, Gaus SE, Huang EJ, Hof PR, Miller BL, et al. Selective frontoinsular von Economo neuron and fork cell loss in early behavioral variant frontotemporal dementia. Cereb Cortex. 2012;22(2):251\u20139.","journal-title":"Cereb Cortex"},{"key":"839_CR81","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00401-018-1942-8","volume":"137","author":"AL Nana","year":"2019","unstructured":"Nana AL, Sidhu M, Gaus SE, Hwang JHL, Li L, Park Y, et al. Neurons selectively targeted in frontotemporal dementia reveal early stage TDP-43 pathobiology. Acta Neuropathol. 2019;137:27\u201346.","journal-title":"Acta Neuropathol."},{"issue":"3","key":"839_CR82","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351(3):602\u201311.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"839_CR83","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3390\/biom11040548","volume":"11","author":"D Pakravan","year":"2021","unstructured":"Pakravan D, Michiels E, Bratek-Skicki A, De Decker M, Van Lindt J, Alsteens D, et al. Liquid\u2013liquid phase separation enhances TDP-43 LCD aggregation but delays seeded aggregation. Biomolecules. 2021;11(4):548.","journal-title":"Biomolecules"},{"key":"839_CR84","doi-asserted-by":"crossref","unstructured":"Gasset-Rosa F, Lu S, Yu H, Chen C, Melamed Ze, Guo L, et al. Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron. 2019;102(2):339\u201357","DOI":"10.1016\/j.neuron.2019.02.038"},{"key":"839_CR85","doi-asserted-by":"crossref","unstructured":"Mann JR, Gleixner AM, Mauna JC, Gomes E, DeChellis-Marks MR, Needham PG, et al. RNA binding antagonizes neurotoxic phase transitions of TDP-43. Neuron. 2019;102(2):321\u201338. e8.","DOI":"10.1016\/j.neuron.2019.01.048"},{"issue":"5","key":"839_CR86","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.molcel.2018.07.002","volume":"71","author":"L McGurk","year":"2018","unstructured":"McGurk L, Gomes E, Guo L, Mojsilovic-Petrovic J, Tran V, Kalb RG, et al. Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization. Mol Cell. 2018;71(5):703-17.e9.","journal-title":"Mol Cell"},{"key":"839_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105078","volume":"146","author":"CG Otte","year":"2020","unstructured":"Otte CG, Fortuna TR, Mann JR, Gleixner AM, Ramesh N, Pyles NJ, et al. Optogenetic TDP-43 nucleation induces persistent insoluble species and progressive motor dysfunction in vivo. Neurobiol Dis. 2020;146: 105078.","journal-title":"Neurobiol Dis"},{"key":"839_CR88","doi-asserted-by":"crossref","unstructured":"Ratti A, Gumina V, Lenzi P, Bossolasco P, Fulceri F, Volpe C, et al. Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons. Neurobiology of Disease. 2020;145.","DOI":"10.1016\/j.nbd.2020.105051"},{"issue":"6529","key":"839_CR89","doi-asserted-by":"publisher","first-page":"eabb4309","DOI":"10.1126\/science.abb4309","volume":"371","author":"H Yu","year":"2021","unstructured":"Yu H, Lu S, Gasior K, Singh D, Vazquez-Sanchez S, Tapia O, et al. HSP70 chaperones RNA-free TDP-43 into anisotropic intranuclear liquid spherical shells. Sci. 2021;371(6529):eabb4309.","journal-title":"Sci."},{"key":"839_CR90","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.39578","volume":"8","author":"P Zhang","year":"2019","unstructured":"Zhang P, Fan B, Yang P, Temirov J, Messing J, Kim HJ, et al. Chronic optogenetic induction of stress granules is cytotoxic and reveals the evolution of ALS-FTD pathology. Elife. 2019;8: e39578.","journal-title":"Elife"},{"issue":"6","key":"839_CR91","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.tcb.2018.02.004","volume":"28","author":"S Boeynaems","year":"2018","unstructured":"Boeynaems S, Alberti S, Fawzi NL, Mittag T, Polymenidou M, Rousseau F, et al. Protein phase separation: a new phase in cell biology. Trends Cell Biol. 2018;28(6):420\u201335.","journal-title":"Trends Cell Biol"},{"issue":"5","key":"839_CR92","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.molcel.2015.01.013","volume":"57","author":"TJ Nott","year":"2015","unstructured":"Nott TJ, Petsalaki E, Farber P, Jervis D, Fussner E, Plochowietz A, et al. Phase transition of a disordered nuage protein generates environmentally responsive membraneless organelles. Mol Cell. 2015;57(5):936\u201347.","journal-title":"Mol Cell"},{"key":"839_CR93","doi-asserted-by":"crossref","unstructured":"Li H-R, Chiang W-C, Chou P-C, Wang W-J, Huang J-r. TAR DNA-binding protein 43 (TDP-43) liquid\u2013liquid phase separation is mediated by just a few aromatic residues. Journal of Biological Chemistry. 2018;293(16):6090\u20138.","DOI":"10.1074\/jbc.AC117.001037"},{"issue":"11","key":"839_CR94","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.1073\/pnas.1912055117","volume":"117","author":"AE Conicella","year":"2020","unstructured":"Conicella AE, Dignon GL, Zerze GH, Schmidt HB, D\u2019Ordine AM, Kim YC, et al. TDP-43 \u03b1-helical structure tunes liquid-liquid phase separation and function. Proc Natl Acad Sci U S A. 2020;117(11):5883\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"839_CR95","doi-asserted-by":"crossref","unstructured":"Shin Y, Brangwynne CP. Liquid phase condensation in cell physiology and disease. Science. 2017;357(6357):eaaf4382.","DOI":"10.1126\/science.aaf4382"},{"issue":"4","key":"839_CR96","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00018-023-04739-2","volume":"80","author":"SS Keating","year":"2023","unstructured":"Keating SS, Bademosi AT, San Gil R, Walker AK. Aggregation-prone TDP-43 sequesters and drives pathological transitions of free nuclear TDP-43. Cell Mol Life Sci. 2023;80(4):95.","journal-title":"Cell Mol Life Sci"},{"issue":"21","key":"839_CR97","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.3390\/ijms20215501","volume":"20","author":"I Owen","year":"2019","unstructured":"Owen I, Shewmaker F. The role of post-translational modifications in the phase transitions of intrinsically disordered proteins. Int J Mol Sci. 2019;20(21):5501.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"839_CR98","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cell.2015.09.015","volume":"163","author":"A Molliex","year":"2015","unstructured":"Molliex A, Temirov J, Lee J, Coughlin M, Kanagaraj AP, Kim HJ, et al. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163(1):123\u201333.","journal-title":"Cell"},{"issue":"9","key":"839_CR99","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.str.2016.07.007","volume":"24","author":"AE Conicella","year":"2016","unstructured":"Conicella AE, Zerze GH, Mittal J, Fawzi NL. ALS mutations disrupt phase separation mediated by \u03b1-helical structure in the TDP-43 low-complexity C-terminal domain. Structure. 2016;24(9):1537\u201349.","journal-title":"Structure"},{"issue":"5","key":"839_CR100","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.cell.2015.07.047","volume":"162","author":"A Patel","year":"2015","unstructured":"Patel A, Lee HO, Jawerth L, Maharana S, Jahnel M, Hein MY, et al. A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell. 2015;162(5):1066\u201377.","journal-title":"Cell"},{"issue":"7","key":"839_CR101","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201798049","volume":"37","author":"S Wegmann","year":"2018","unstructured":"Wegmann S, Eftekharzadeh B, Tepper K, Zoltowska KM, Bennett RE, Dujardin S, et al. Tau protein liquid\u2013liquid phase separation can initiate tau aggregation. EMBO J. 2018;37(7): e98049.","journal-title":"EMBO J"},{"issue":"5","key":"839_CR102","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41582-019-0157-5","volume":"15","author":"NB Nedelsky","year":"2019","unstructured":"Nedelsky NB, Taylor JP. Bridging biophysics and neurology: aberrant phase transitions in neurodegenerative disease. Nat Rev Neurol. 2019;15(5):272\u201386.","journal-title":"Nat Rev Neurol"},{"key":"839_CR103","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/bs.apcsb.2019.08.002","volume":"118","author":"GA de Oliveira","year":"2019","unstructured":"de Oliveira GA, Cordeiro Y, Silva JL, Vieira TC. Liquid-liquid phase transitions and amyloid aggregation in proteins related to cancer and neurodegenerative diseases. Adv Protein Chem Struct Biol. 2019;118:289\u2013331.","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"2","key":"839_CR104","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.molcel.2015.08.018","volume":"60","author":"Y Lin","year":"2015","unstructured":"Lin Y, Protter DS, Rosen MK, Parker R. Formation and maturation of phase-separated liquid droplets by RNA-binding proteins. Mol Cell. 2015;60(2):208\u201319.","journal-title":"Mol Cell"},{"issue":"4","key":"839_CR105","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1074\/mcp.M800390-MCP200","volume":"9","author":"NT Seyfried","year":"2010","unstructured":"Seyfried NT, Gozal YM, Dammer EB, Xia Q, Duong DM, Cheng D, et al. Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains. Mol Cell Proteomics. 2010;9(4):705\u201318.","journal-title":"Mol Cell Proteomics"},{"issue":"30","key":"839_CR106","doi-asserted-by":"publisher","first-page":"20329","DOI":"10.1074\/jbc.M109.010264","volume":"284","author":"BS Johnson","year":"2009","unstructured":"Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem. 2009;284(30):20329\u201339.","journal-title":"J Biol Chem"},{"issue":"5935","key":"839_CR107","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1126\/science.1172046","volume":"324","author":"CP Brangwynne","year":"2009","unstructured":"Brangwynne CP, Eckmann CR, Courson DS, Rybarska A, Hoege C, Gharakhani J, et al. Germline P granules are liquid droplets that localize by controlled dissolution\/condensation. Science. 2009;324(5935):1729\u201332.","journal-title":"Science"},{"key":"839_CR108","doi-asserted-by":"crossref","unstructured":"Erwin AL, Chang ML, Fernandez MG, Attili D, Russ JE, Sutanto R, et al. Molecular Visualization of Neuronal TDP43 Pathology In Situ. bioRxiv. 2024.","DOI":"10.1101\/2024.08.19.608477"},{"issue":"4","key":"839_CR109","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nn.2779","volume":"14","author":"M Polymenidou","year":"2011","unstructured":"Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci. 2011;14(4):459\u201368.","journal-title":"Nat Neurosci"},{"key":"839_CR110","doi-asserted-by":"crossref","unstructured":"Iguchi Y, Katsuno M, Niwa J-i, Takagi S, Ishigaki S, Ikenaka K, et al. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain. 2013;136(5):1371\u201382.","DOI":"10.1093\/brain\/awt029"},{"key":"839_CR111","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neuroscience.2015.02.046","volume":"293","author":"M \u0160talekar","year":"2015","unstructured":"\u0160talekar M, Yin X, Rebolj K, Darovic S, Troakes C, Mayr M, et al. Proteomic analyses reveal that loss of TDP-43 affects RNA processing and intracellular transport. Neuroscience. 2015;293:157\u201370.","journal-title":"Neuroscience"},{"issue":"2","key":"839_CR112","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1172\/JCI44867","volume":"121","author":"LM Igaz","year":"2011","unstructured":"Igaz LM, Kwong LK, Lee EB, Chen-Plotkin A, Swanson E, Unger T, et al. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J Clin Investig. 2011;121(2):726\u201338.","journal-title":"J Clin Investig"},{"issue":"10","key":"839_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141836","volume":"10","author":"A Amlie-Wolf","year":"2015","unstructured":"Amlie-Wolf A, Ryvkin P, Tong R, Dragomir I, Suh E, Xu Y, et al. Transcriptomic changes due to cytoplasmic TDP-43 expression reveal dysregulation of histone transcripts and nuclear chromatin. PLoS ONE. 2015;10(10): e0141836.","journal-title":"PLoS ONE"},{"key":"839_CR114","doi-asserted-by":"crossref","unstructured":"Marks JD, Ayuso VE, Carlomagno Y, Yue M, Todd TW, Hao Y, et al. TMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia. Science translational medicine. 2024;16(730):eadf9735.","DOI":"10.1126\/scitranslmed.adf9735"},{"issue":"16","key":"839_CR115","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.1128\/jb.178.16.4759-4764.1996","volume":"178","author":"PJ Kennelly","year":"1996","unstructured":"Kennelly PJ, Potts M. Fancy meeting you here! A fresh look at\" prokaryotic\" protein phosphorylation. J Bacteriol. 1996;178(16):4759\u201364.","journal-title":"J Bacteriol"},{"key":"839_CR116","doi-asserted-by":"crossref","unstructured":"Dinkel H, Chica C, Via A, Gould CM, Jensen LJ, Gibson TJ, et al. Phospho. ELM: a database of phosphorylation sites\u2014update 2011. Nucleic acids research. 2010;39(suppl_1):D261-D7.","DOI":"10.1093\/nar\/gkq1104"},{"issue":"9","key":"839_CR117","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1021\/acschembio.3c00068","volume":"18","author":"AK Pandey","year":"2023","unstructured":"Pandey AK, Ganguly HK, Sinha SK, Daniels KE, Yap GP, Patel S, et al. An inherent difference between serine and threonine phosphorylation: phosphothreonine strongly prefers a highly ordered, compact, cyclic conformation. ACS Chem Biol. 2023;18(9):1938\u201358.","journal-title":"ACS Chem Biol"},{"issue":"4","key":"839_CR118","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1017\/S0033583511000060","volume":"44","author":"HJ Dyson","year":"2011","unstructured":"Dyson HJ. Expanding the proteome: disordered and alternatively folded proteins. Q Rev Biophys. 2011;44(4):467\u2013518.","journal-title":"Q Rev Biophys"},{"issue":"3","key":"839_CR119","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/nar\/gkh253","volume":"32","author":"LM Iakoucheva","year":"2004","unstructured":"Iakoucheva LM, Radivojac P, Brown CJ, O\u2019Connor TR, Sikes JG, Obradovic Z, et al. The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res. 2004;32(3):1037\u201349.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"839_CR120","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1074\/mcp.M700564-MCP200","volume":"7","author":"MO Collins","year":"2008","unstructured":"Collins MO, Yu L, Campuzano I, Grant SG, Choudhary JS. Phosphoproteomic analysis of the mouse brain cytosol reveals a predominance of protein phosphorylation in regions of intrinsic sequence disorder. Mol Cell Proteomics. 2008;7(7):1331\u201348.","journal-title":"Mol Cell Proteomics"},{"issue":"13","key":"839_CR121","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.1074\/jbc.R115.695056","volume":"291","author":"A Bah","year":"2016","unstructured":"Bah A, Forman-Kay JD. Modulation of intrinsically disordered protein function by post-translational modifications. J Biol Chem. 2016;291(13):6696\u2013705.","journal-title":"J Biol Chem"},{"issue":"4","key":"839_CR122","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00401-016-1600-y","volume":"132","author":"NF Liachko","year":"2016","unstructured":"Liachko NF, Saxton AD, McMillan PJ, Strovas TJ, Currey HN, Taylor LM, et al. The phosphatase calcineurin regulates pathological TDP-43 phosphorylation. Acta Neuropathol. 2016;132(4):545\u201361.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"839_CR123","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1007\/s11064-019-02832-2","volume":"45","author":"DA Hicks","year":"2020","unstructured":"Hicks DA, Cross LL, Williamson R, Rattray M. Endoplasmic reticulum stress signalling induces casein kinase 1-dependent formation of cytosolic TDP-43 inclusions in motor neuron-like cells. Neurochem Res. 2020;45(6):1354\u201364.","journal-title":"Neurochem Res"},{"issue":"3","key":"839_CR124","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1096\/fj.02-0473rev","volume":"17","author":"F Meggio","year":"2003","unstructured":"Meggio F, Pinna LA. One-thousand-and-one substrates of protein kinase CK2? FASEB J. 2003;17(3):349\u201368.","journal-title":"FASEB J"},{"issue":"1","key":"839_CR125","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1038\/srep03460","volume":"3","author":"Y Bian","year":"2013","unstructured":"Bian Y, Ye M, Wang C, Cheng K, Song C, Dong M, et al. Global screening of CK2 kinase substrates by an integrated phosphoproteomics workflow. Sci Rep. 2013;3(1):3460.","journal-title":"Sci Rep"},{"key":"839_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.835733","volume":"10","author":"A Kozelekov\u00e1","year":"2022","unstructured":"Kozelekov\u00e1 A, N\u00e1plavov\u00e1 A, Brom T, Ga\u0161parik N, \u0160imek J, Houser J, et al. Phosphorylated and Phosphomimicking Variants May Differ\u2014A Case Study of 14-3-3 Protein. Front Chem. 2022;10: 835733.","journal-title":"Front Chem"},{"issue":"24","key":"839_CR127","doi-asserted-by":"publisher","first-page":"16895","DOI":"10.1074\/jbc.M800747200","volume":"283","author":"KE Paleologou","year":"2008","unstructured":"Paleologou KE, Schmid AW, Rospigliosi CC, Kim H-Y, Lamberto GR, Fredenburg RA, et al. Phosphorylation at Ser-129 but not the phosphomimics S129E\/D inhibits the fibrillation of \u03b1-synuclein. J Biol Chem. 2008;283(24):16895\u2013905.","journal-title":"J Biol Chem"},{"key":"839_CR128","doi-asserted-by":"crossref","unstructured":"Haider R, Shipley B, Surewicz K, Hinczewski M, Surewicz WK. Pathological C-terminal phosphomimetic substitutions alter the mechanism of liquid-liquid phase separation of TDP-43 low complexity domain. bioRxiv. 2024.","DOI":"10.1101\/2024.03.21.586202"},{"issue":"4","key":"839_CR129","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1471-4159.2009.06383.x","volume":"111","author":"C Colombrita","year":"2009","unstructured":"Colombrita C, Zennaro E, Fallini C, Weber M, Sommacal A, Buratti E, et al. TDP-43 is recruited to stress granules in conditions of oxidative insult. J Neurochem. 2009;111(4):1051\u201361.","journal-title":"J Neurochem"},{"key":"839_CR130","doi-asserted-by":"crossref","unstructured":"Iguchi Y, Katsuno M, Takagi S, Ishigaki S, Niwa J-i, Hasegawa M, et al. Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies. Neurobiology of disease. 2012;45(3):862\u201370.","DOI":"10.1016\/j.nbd.2011.12.002"},{"issue":"16","key":"839_CR131","doi-asserted-by":"publisher","first-page":"8975","DOI":"10.3390\/ijms22168975","volume":"22","author":"L Mart\u00ednez-Gonz\u00e1lez","year":"2021","unstructured":"Mart\u00ednez-Gonz\u00e1lez L, Gonzalo-Consuegra C, G\u00f3mez-Almer\u00eda M, Porras G, de Lago E, Mart\u00edn-Requero \u00c1, et al. Tideglusib, a non-ATP competitive inhibitor of GSK-3\u03b2 as a drug candidate for the treatment of amyotrophic lateral sclerosis. Int J Mol Sci. 2021;22(16):8975.","journal-title":"Int J Mol Sci"},{"key":"839_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-020-00420-5","volume":"16","author":"S Kumar","year":"2021","unstructured":"Kumar S, Phaneuf D, Cordeau P, Boutej H, Kriz J, Julien J-P. Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS\/FTD. Mol Neurodegener. 2021;16:1\u201317.","journal-title":"Mol Neurodegener"},{"key":"839_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.906437","volume":"9","author":"DV Laurents","year":"2022","unstructured":"Laurents DV. AlphaFold 2 and NMR spectroscopy: partners to understand protein structure, dynamics and function. Front Mol Biosci. 2022;9: 906437.","journal-title":"Front Mol Biosci"},{"key":"839_CR134","doi-asserted-by":"crossref","unstructured":"Stefanoska K, Gajwani M, Tan ARP, Ahel HI, Asih PR, Volkerling A, et al. Alzheimer's disease: Ablating single master site abolishes tau hyperphosphorylation. Science Advances. 2022;8(27):eabl8809.","DOI":"10.1126\/sciadv.abl8809"},{"issue":"2","key":"839_CR135","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1046\/j.1471-4159.2003.01670.x","volume":"85","author":"JH Hu","year":"2003","unstructured":"Hu JH, Zhang H, Wagey R, Krieger C, Pelech S. Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord. J Neurochem. 2003;85(2):432\u201342.","journal-title":"J Neurochem"},{"issue":"3","key":"839_CR136","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00401-010-0759-x","volume":"121","author":"V Vingtdeux","year":"2011","unstructured":"Vingtdeux V, Davies P, Dickson DW, Marambaud P. AMPK is abnormally activated in tangle-and pre-tangle-bearing neurons in Alzheimer\u2019s disease and other tauopathies. Acta Neuropathol. 2011;121(3):337\u201349.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"839_CR137","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.febslet.2014.12.029","volume":"589","author":"Y-J Liu","year":"2015","unstructured":"Liu Y-J, Lee L-M, Lai H-L, Chern Y. Aberrant activation of AMP-activated protein kinase contributes to the abnormal distribution of HuR in amyotrophic lateral sclerosis. FEBS Lett. 2015;589(4):432\u20139.","journal-title":"FEBS Lett"},{"issue":"7","key":"839_CR138","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1073\/pnas.0308512100","volume":"101","author":"EM Blalock","year":"2004","unstructured":"Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer\u2019s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci. 2004;101(7):2173\u20138.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"839_CR139","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-2990.2006.00795.x","volume":"33","author":"K Leroy","year":"2007","unstructured":"Leroy K, Yilmaz Z, Brion JP. Increased level of active GSK-3\u03b2 in Alzheimer\u2019s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol Appl Neurobiol. 2007;33(1):43\u201355.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"8","key":"839_CR140","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1111\/j.1460-9568.2005.04391.x","volume":"22","author":"F Liu","year":"2005","unstructured":"Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci. 2005;22(8):1942\u201350.","journal-title":"Eur J Neurosci"},{"issue":"10","key":"839_CR141","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3390\/brainsci10100675","volume":"10","author":"H-J Choi","year":"2020","unstructured":"Choi H-J, Cha SJ, Lee J-W, Kim H-J, Kim K. Recent advances on the role of gsk3\u03b2 in the pathogenesis of amyotrophic lateral sclerosis. Brain Sci. 2020;10(10):675.","journal-title":"Brain Sci"},{"issue":"1","key":"839_CR142","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0006-8993(00)02200-9","volume":"865","author":"K Yasojima","year":"2000","unstructured":"Yasojima K, Kuret J, DeMaggio AJ, McGeer E, McGeer PL. Casein kinase 1 delta mRNA is upregulated in Alzheimer disease brain. Brain Res. 2000;865(1):116\u201320.","journal-title":"Brain Res"},{"key":"839_CR143","doi-asserted-by":"crossref","unstructured":"San Gil R, Pascovici D, Venturato J, Brown-Wright H, Mehta P, Madrid San Martin L, et al. A transient protein folding response targets aggregation in the early phase of TDP-43-mediated disease. bioRxiv. 2023:2023.06. 21.546009.","DOI":"10.1101\/2023.06.21.546009"},{"issue":"4","key":"839_CR144","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0002-9440(10)65219-4","volume":"155","author":"N Ghoshal","year":"1999","unstructured":"Ghoshal N, Smiley JF, DeMaggio AJ, Hoekstra MF, Cochran EJ, Binder LI, et al. A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer\u2019s disease. Am J Pathol. 1999;155(4):1163\u201372.","journal-title":"Am J Pathol"},{"key":"839_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.733700","volume":"11","author":"A Siddiqui","year":"2021","unstructured":"Siddiqui A, Tumiati M, Joko A, Sandholm J, Roering P, Aakko S, et al. Targeting dna homologous repair proficiency with concomitant topoisomerase ii and c-abl inhibition. Front Oncol. 2021;11: 733700.","journal-title":"Front Oncol"},{"issue":"11","key":"839_CR146","doi-asserted-by":"publisher","first-page":"7470","DOI":"10.1074\/jbc.275.11.7470","volume":"275","author":"X Sun","year":"2000","unstructured":"Sun X, Wu F, Datta R, Kharbanda S, Kufe D. Interaction between protein kinase C \u03b4 and the c-Abl tyrosine kinase in the cellular response to oxidative stress. J Biol Chem. 2000;275(11):7470\u20133.","journal-title":"J Biol Chem"},{"issue":"23","key":"839_CR147","doi-asserted-by":"publisher","first-page":"17237","DOI":"10.1074\/jbc.C000099200","volume":"275","author":"X Sun","year":"2000","unstructured":"Sun X, Majumder P, Shioya H, Wu F, Kumar S, Weichselbaum R, et al. Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen species. J Biol Chem. 2000;275(23):17237\u201340.","journal-title":"J Biol Chem"},{"issue":"1","key":"839_CR148","volume":"2012","author":"S Gonfloni","year":"2012","unstructured":"Gonfloni S, Maiani E, Di Bartolomeo C, Diederich M, Cesareni G. Oxidative stress, DNA damage, and c-Abl signaling: At the crossroad in neurodegenerative diseases? International journal of cell biology. 2012;2012(1): 683097.","journal-title":"International journal of cell biology"},{"issue":"2","key":"839_CR149","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/ana.20379","volume":"57","author":"YM Jiang","year":"2005","unstructured":"Jiang YM, Yamamoto M, Kobayashi Y, Yoshihara T, Liang Y, Terao S, et al. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann Neurol. 2005;57(2):236\u201351.","journal-title":"Ann Neurol"},{"key":"839_CR150","doi-asserted-by":"crossref","unstructured":"Katsumata R, Ishigaki S, Katsuno M, Kawai K, Sone J, Huang Z, et al. c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis. 2012.","DOI":"10.1371\/journal.pone.0046185"},{"key":"839_CR151","doi-asserted-by":"crossref","unstructured":"Imamura K, Izumi Y, Watanabe A, Tsukita K, Woltjen K, Yamamoto T, et al. The Src\/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. Science Translational Medicine. 2017;9(391):eaaf3962.","DOI":"10.1126\/scitranslmed.aaf3962"},{"issue":"1\u20132","key":"839_CR152","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mrfmmm.2003.08.008","volume":"532","author":"JM Kim","year":"2003","unstructured":"Kim JM, Yamada M, Masai H. Functions of mammalian Cdc7 kinase in initiation\/monitoring of DNA replication and development. Mutat Res. 2003;532(1\u20132):29\u201340.","journal-title":"Mutat Res"},{"issue":"7","key":"839_CR153","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1128\/MCB.19.7.4888","volume":"19","author":"G Oshiro","year":"1999","unstructured":"Oshiro G, Owens JC, Shellman Y, Sclafani RA, Li JJ. Cell cycle control of Cdc7p kinase activity through regulation of Dbf4p stability. Mol Cell Biol. 1999;19(7):4888\u201396.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"839_CR154","first-page":"2899","volume":"13","author":"A Jackson","year":"1993","unstructured":"Jackson A, Pahl P, Harrison K, Rosamond J, Sclafani R. Cell cycle regulation of the yeast Cdc7 protein kinase by association with the Dbf4 protein. Mol Cell Biol. 1993;13(5):2899\u2013908.","journal-title":"Mol Cell Biol"},{"issue":"19","key":"839_CR155","doi-asserted-by":"publisher","first-page":"5334","DOI":"10.1093\/emboj\/18.19.5334","volume":"18","author":"M Weinreich","year":"1999","unstructured":"Weinreich M, Stillman B. Cdc7p\u2013Dbf4p kinase binds to chromatin during S phase and is regulated by both the APC and the RAD53 checkpoint pathway. EMBO J. 1999;18(19):5334\u201346.","journal-title":"EMBO J"},{"issue":"12","key":"839_CR156","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1093\/emboj\/cdf290","volume":"21","author":"A Montagnoli","year":"2002","unstructured":"Montagnoli A, Bosotti R, Villa F, Rialland M, Brotherton D, Mercurio C, et al. Drf1, a novel regulatory subunit for human Cdc7 kinase. EMBO J. 2002;21(12):3171\u201381.","journal-title":"EMBO J"},{"issue":"8","key":"839_CR157","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.str.2020.05.010","volume":"28","author":"SD Dick","year":"2020","unstructured":"Dick SD, Federico S, Hughes SM, Pye VE, O\u2019Reilly N, Cherepanov P. Structural Basis for the Activation and Target Site Specificity of CDC7 Kinase. Structure. 2020;28(8):954-62.e4.","journal-title":"Structure"},{"issue":"1","key":"839_CR158","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1128\/MCB.20.1.242-248.2000","volume":"20","author":"MF Ferreira","year":"2000","unstructured":"Ferreira MF, Santocanale C, Drury LS, Diffley JF. Dbf4p, an essential S phase-promoting factor, is targeted for degradation by the anaphase-promoting complex. Mol Cell Biol. 2000;20(1):242\u20138.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"839_CR159","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cellsig.2004.12.011","volume":"17","author":"U Knippschild","year":"2005","unstructured":"Knippschild U, Gocht A, Wolff S, Huber N, L\u00f6hler J, St\u00f6ter M. The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. Cell Signal. 2005;17(6):675\u201389.","journal-title":"Cell Signal"},{"issue":"4","key":"839_CR160","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.biocel.2010.12.004","volume":"43","author":"JK Cheong","year":"2011","unstructured":"Cheong JK, Virshup DM. Casein kinase 1: Complexity in the family. Int J Biochem Cell Biol. 2011;43(4):465\u20139.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"839_CR161","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/1476-4598-13-231","volume":"13","author":"B Schittek","year":"2014","unstructured":"Schittek B, Sinnberg T. Biological functions of casein kinase 1 isoforms and putative roles in tumorigenesis. Mol Cancer. 2014;13(1):231.","journal-title":"Mol Cancer"},{"issue":"21","key":"839_CR162","doi-asserted-by":"publisher","first-page":"9548","DOI":"10.1073\/pnas.88.21.9548","volume":"88","author":"J Rowles","year":"1991","unstructured":"Rowles J, Slaughter C, Moomaw C, Hsu J, Cobb MH. Purification of casein kinase I and isolation of cDNAs encoding multiple casein kinase I-like enzymes. Proc Natl Acad Sci USA. 1991;88(21):9548\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"25","key":"839_CR163","doi-asserted-by":"publisher","first-page":"14875","DOI":"10.1074\/jbc.270.25.14875","volume":"270","author":"KJ Fish","year":"1995","unstructured":"Fish KJ, Cegielska A, Getman ME, Landes GM, Virshup DM. Isolation and Characterization of Human Casein Kinase I\u220a (CKI), a Novel Member of the CKI Gene Family (\u2217). J Biol Chem. 1995;270(25):14875\u201383.","journal-title":"J Biol Chem"},{"issue":"10","key":"839_CR164","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0898-6568(98)00042-4","volume":"10","author":"SD Gross","year":"1998","unstructured":"Gross SD, Anderson RA. Casein Kinase I: Spatial Organization and Positioning of a Multifunctional Protein Kinase Family. Cell Signal. 1998;10(10):699\u2013711.","journal-title":"Cell Signal"},{"issue":"21","key":"839_CR165","doi-asserted-by":"publisher","first-page":"12717","DOI":"10.1074\/jbc.270.21.12717","volume":"270","author":"L Zhai","year":"1995","unstructured":"Zhai L, Graves PR, Robinson LC, Italiano M, Culbertson MR, Rowles J, et al. Casein kinase I\u03b3 subfamily: Molecular cloning, expression, and characterization of three mammalian isoforms and complementation of defects in the Saccharomyces cerevisiae YCK genes. J Biol Chem. 1995;270(21):12717\u201324.","journal-title":"J Biol Chem"},{"issue":"7069","key":"839_CR166","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/nature04170","volume":"438","author":"G Davidson","year":"2005","unstructured":"Davidson G, Wu W, Shen J, Bilic J, Fenger U, Stannek P, et al. Casein kinase 1 \u03b3 couples Wnt receptor activation to cytoplasmic signal transduction. Nature. 2005;438(7069):867\u201372.","journal-title":"Nature"},{"issue":"2","key":"839_CR167","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.bbrc.2009.03.038","volume":"382","author":"F Kametani","year":"2009","unstructured":"Kametani F, Nonaka T, Suzuki T, Arai T, Dohmae N, Akiyama H, et al. Identification of casein kinase-1 phosphorylation sites on TDP-43. Biochem Biophys Res Commun. 2009;382(2):405\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"31","key":"839_CR168","doi-asserted-by":"publisher","first-page":"23523","DOI":"10.1074\/jbc.M002850200","volume":"275","author":"J Walter","year":"2000","unstructured":"Walter J, Schindzielorz A, Hartung B, Haass C. Phosphorylation of the \u03b2-Amyloid precursor protein at the cell surface by ectocasein kinases 1 and 2. J Biol Chem. 2000;275(31):23523\u20139.","journal-title":"J Biol Chem"},{"issue":"32","key":"839_CR169","doi-asserted-by":"publisher","first-page":"23645","DOI":"10.1074\/jbc.M703269200","volume":"282","author":"DP Hanger","year":"2007","unstructured":"Hanger DP, Byers HL, Wray S, Leung K-Y, Saxton MJ, Seereeram A, et al. Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J Biol Chem. 2007;282(32):23645\u201354.","journal-title":"J Biol Chem"},{"issue":"16","key":"839_CR170","doi-asserted-by":"publisher","first-page":"15938","DOI":"10.1074\/jbc.M314116200","volume":"279","author":"G Li","year":"2004","unstructured":"Li G, Yin H, Kuret J. Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules. J Biol Chem. 2004;279(16):15938\u201345.","journal-title":"J Biol Chem"},{"issue":"4","key":"839_CR171","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0197-4580(00)00110-X","volume":"21","author":"C Schwab","year":"2000","unstructured":"Schwab C, DeMaggio AJ, Ghoshal N, Binder LI, Kuret J, McGeer PL. Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases. Neurobiol Aging. 2000;21(4):503\u201310.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"839_CR172","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1074\/jbc.275.1.390","volume":"275","author":"M Okochi","year":"2000","unstructured":"Okochi M, Walter J, Koyama A, Nakajo S, Baba M, Iwatsubo T, et al. Constitutive phosphorylation of the Parkinson\u2019s disease associated \u03b1-synuclein. J Biol Chem. 2000;275(1):390\u20137.","journal-title":"J Biol Chem"},{"key":"839_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106516","volume":"196","author":"VI Ko","year":"2024","unstructured":"Ko VI, Ong K, Cleveland DW, Yu H, Ravits JM. CK1\u03b4\/\u03b5 kinases regulate TDP-43 phosphorylation and are therapeutic targets for ALS-related TDP-43 hyperphosphorylation. Neurobiol Dis. 2024;196: 106516.","journal-title":"Neurobiol Dis"},{"key":"839_CR174","doi-asserted-by":"crossref","unstructured":"Ko VI, Ong K, Kwon DY, Li X, Pietrasiewicz A, Harvey JS, et al. CK1\u03b4\/e-mediated TDP-43 phosphorylation contributes to early motor neuron disease toxicity in amyotrophic lateral sclerosis. 2024.","DOI":"10.21203\/rs.3.rs-5334588\/v1"},{"issue":"1","key":"839_CR175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20021469","volume":"369","author":"DW Litchfield","year":"2003","unstructured":"Litchfield DW. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochemical Journal. 2003;369(1):1\u201315.","journal-title":"Biochemical Journal"},{"key":"839_CR176","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.advenzreg.2008.04.002","volume":"48","author":"KA Ahmad","year":"2008","unstructured":"Ahmad KA, Wang G, Unger G, Slaton J, Ahmed K. Protein kinase CK2-a key suppressor of apoptosis. Adv Enzyme Regul. 2008;48:179.","journal-title":"Adv Enzyme Regul"},{"key":"839_CR177","doi-asserted-by":"crossref","unstructured":"Sarno S, Ghisellini P, Pinna LA. Unique activation mechanism of protein kinase CK2. The N-terminal segment is essential for constitutive activity of the catalytic subunit but not of the holoenzyme. J Biol Chem. 2002;277(25):22509\u201314.","DOI":"10.1074\/jbc.M200486200"},{"issue":"24","key":"839_CR178","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1016\/j.febslet.2007.08.067","volume":"581","author":"A Ishii","year":"2007","unstructured":"Ishii A, Nonaka T, Taniguchi S, Saito T, Arai T, Mann D, et al. Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human \u03b1-synuclein: implication for \u03b1-synucleinopathies. FEBS Lett. 2007;581(24):4711\u20137.","journal-title":"FEBS Lett"},{"issue":"8","key":"839_CR179","doi-asserted-by":"publisher","first-page":"6834","DOI":"10.1074\/jbc.M312760200","volume":"279","author":"G Lee","year":"2004","unstructured":"Lee G, Tanaka M, Park K, Lee SS, Kim YM, Junn E, et al. Casein kinase II-mediated phosphorylation regulates \u03b1-synuclein\/synphilin-1 interaction and inclusion body formation. J Biol Chem. 2004;279(8):6834\u20139.","journal-title":"J Biol Chem"},{"key":"839_CR180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-021-01281-9","volume":"9","author":"K Sano","year":"2021","unstructured":"Sano K, Iwasaki Y, Yamashita Y, Irie K, Hosokawa M, Satoh K, et al. Tyrosine 136 phosphorylation of \u03b1-synuclein aggregates in the Lewy body dementia brain: involvement of serine 129 phosphorylation by casein kinase 2. Acta Neuropathol Commun. 2021;9:1\u201317.","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"839_CR181","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232019","volume":"15","author":"W Wu","year":"2020","unstructured":"Wu W, Sung CC, Yu P, Li J, Chung KK. S-Nitrosylation of G protein-coupled receptor kinase 6 and Casein kinase 2 alpha modulates their kinase activity toward alpha-synuclein phosphorylation in an animal model of Parkinson\u2019s disease. PLoS ONE. 2020;15(4): e0232019.","journal-title":"PLoS ONE"},{"key":"839_CR182","doi-asserted-by":"crossref","unstructured":"Greenwood JA, Scott CW, Spreen RC, Caputo CB, Johnson GV. Casein kinase II preferentially phosphorylates human tau isoforms containing an amino-terminal insert. Identification of threonine 39 as the primary phosphate acceptor. Journal of Biological Chemistry. 1994;269(6):4373\u201380.","DOI":"10.1016\/S0021-9258(17)41790-X"},{"issue":"11","key":"839_CR183","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nri2423","volume":"8","author":"S Ghosh","year":"2008","unstructured":"Ghosh S, Hayden MS. New regulators of NF-\u03baB in inflammation. Nat Rev Immunol. 2008;8(11):837\u201348.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"839_CR184","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.cell.2015.01.028","volume":"160","author":"Z Tang","year":"2015","unstructured":"Tang Z, Dai S, He Y, Doty RA, Shultz LD, Sampson SB, et al. MEK guards proteome stability and inhibits tumor-suppressive amyloidogenesis via HSF1. Cell. 2015;160(4):729\u201344.","journal-title":"Cell"},{"issue":"42","key":"839_CR185","doi-asserted-by":"publisher","first-page":"43861","DOI":"10.1074\/jbc.M406240200","volume":"279","author":"S Ussar","year":"2004","unstructured":"Ussar S, Voss T. MEK1 and MEK2, different regulators of the G1\/S transition. J Biol Chem. 2004;279(42):43861\u20139.","journal-title":"J Biol Chem"},{"key":"839_CR186","doi-asserted-by":"crossref","unstructured":"Shaul YD, Seger R. The MEK\/ERK cascade: from signaling specificity to diverse functions. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2007;1773(8):1213\u201326.","DOI":"10.1016\/j.bbamcr.2006.10.005"},{"issue":"5","key":"839_CR187","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/brain\/aww028","volume":"139","author":"H-J Chen","year":"2016","unstructured":"Chen H-J, Mitchell JC, Novoselov S, Miller J, Nishimura AL, Scotter EL, et al. The heat shock response plays an important role in TDP-43 clearance: evidence for dysfunction in amyotrophic lateral sclerosis. Brain. 2016;139(5):1417\u201332.","journal-title":"Brain"},{"issue":"3","key":"839_CR188","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090452","volume":"9","author":"Y Carlomagno","year":"2014","unstructured":"Carlomagno Y, Zhang Y, Davis M, Lin W-L, Cook C, Dunmore J, et al. Casein kinase II induced polymerization of soluble TDP-43 into filaments is inhibited by heat shock proteins. PLoS ONE. 2014;9(3): e90452.","journal-title":"PLoS ONE"},{"issue":"1","key":"839_CR189","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0898-6568(99)00071-6","volume":"12","author":"K Ono","year":"2000","unstructured":"Ono K, Han J. The p38 signal transduction pathway activation and function. Cell Signal. 2000;12(1):1\u201313.","journal-title":"Cell Signal"},{"issue":"2","key":"839_CR190","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1152\/physrev.2001.81.2.807","volume":"81","author":"JM Kyriakis","year":"2001","unstructured":"Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 2001;81(2):807\u201369.","journal-title":"Physiol Rev"},{"issue":"5","key":"839_CR191","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1111\/j.1471-4159.2006.04059.x","volume":"98","author":"S Sato","year":"2006","unstructured":"Sato S, Cerny RL, Buescher JL, Ikezu T. Tau-tubulin kinase 1 (TTBK1), a neuron-specific tau kinase candidate, is involved in tau phosphorylation and aggregation. J Neurochem. 2006;98(5):1573\u201384.","journal-title":"J Neurochem"},{"issue":"3","key":"839_CR192","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0014-5793(01)02256-6","volume":"492","author":"K Tomizawa","year":"2001","unstructured":"Tomizawa K, Omori A, Ohtake A, Sato K, Takahashi M. Tau-tubulin kinase phosphorylates tau at Ser-208 and Ser-210, sites found in paired helical filament-tau. FEBS Lett. 2001;492(3):221\u20137.","journal-title":"FEBS Lett"},{"key":"839_CR193","doi-asserted-by":"crossref","unstructured":"Hasan R, Humphrey J, Bettencourt C, Newcombe J, Consortium NA, Lashley T, et al. Transcriptomic analysis of frontotemporal lobar degeneration with TDP-43 pathology reveals cellular alterations across multiple brain regions. Acta Neuropathologica. 2021:1\u201319.","DOI":"10.1101\/2021.10.06.21264635"},{"issue":"13","key":"839_CR194","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1128\/MCB.20.13.4888-4899.2000","volume":"20","author":"E Vielhaber","year":"2000","unstructured":"Vielhaber E, Eide E, Rivers A, Gao Z-H, Virshup DM. Nuclear entry of the circadian regulator mPER1 is controlled by mammalian casein kinase I \u025b. Mol Cell Biol. 2000;20(13):4888\u201399.","journal-title":"Mol Cell Biol"},{"issue":"7","key":"839_CR195","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0092-8674(01)00610-9","volume":"107","author":"C Lee","year":"2001","unstructured":"Lee C, Etchegaray J-P, Cagampang FR, Loudon AS, Reppert SM. Posttranslational mechanisms regulate the mammalian circadian clock. Cell. 2001;107(7):855\u201367.","journal-title":"Cell"},{"key":"839_CR196","doi-asserted-by":"crossref","unstructured":"Canever JB, Queiroz LY, Soares ES, de Avelar NCP, Cimarosti HI. Circadian rhythm alterations affecting the pathology of neurodegenerative diseases. Journal of Neurochemistry. 2023.","DOI":"10.1111\/jnc.15883"},{"key":"839_CR197","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fneur.2018.00218","volume":"9","author":"Z Huang","year":"2018","unstructured":"Huang Z, Liu Q, Peng Y, Dai J, Xie Y, Chen W, et al. Circadian rhythm dysfunction accelerates disease progression in a mouse model with amyotrophic lateral sclerosis. Front Neurol. 2018;9:218.","journal-title":"Front Neurol"},{"key":"839_CR198","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2018.08.025","volume":"72","author":"T Zhang","year":"2018","unstructured":"Zhang T, Jiang X, Xu M, Wang H, Sang X, Qin M, et al. Sleep and circadian abnormalities precede cognitive deficits in R521C FUS knockin rats. Neurobiol Aging. 2018;72:159\u201370.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"839_CR199","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4161\/org.4.2.5851","volume":"4","author":"Y Komiya","year":"2008","unstructured":"Komiya Y, Habas R. Wnt signal transduction pathways. Organogenesis. 2008;4(2):68\u201375.","journal-title":"Organogenesis"},{"issue":"6","key":"839_CR200","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0092-8674(02)00685-2","volume":"108","author":"C Liu","year":"2002","unstructured":"Liu C, Li Y, Semenov M, Han C, Baeg G-H, Tan Y, et al. Control of \u03b2-catenin phosphorylation\/degradation by a dual-kinase mechanism. Cell. 2002;108(6):837\u201347.","journal-title":"Cell"},{"issue":"9","key":"839_CR201","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1101\/gad.230302","volume":"16","author":"S Amit","year":"2002","unstructured":"Amit S, Hatzubai A, Birman Y, Andersen JS, Ben-Shushan E, Mann M, et al. Axin-mediated CKI phosphorylation of \u03b2-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev. 2002;16(9):1066\u201376.","journal-title":"Genes Dev"},{"key":"839_CR202","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1007\/s12035-019-1547-9","volume":"56","author":"C Gonz\u00e1lez-Fern\u00e1ndez","year":"2019","unstructured":"Gonz\u00e1lez-Fern\u00e1ndez C, Gonzalez P, Andres-Benito P, Ferrer I, Rodr\u00edguez FJ. Wnt signaling alterations in the human spinal cord of amyotrophic lateral sclerosis cases: spotlight on Fz2 and Wnt5a. Mol Neurobiol. 2019;56:6777\u201391.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"839_CR203","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/cells10040839","volume":"10","author":"X Jiang","year":"2021","unstructured":"Jiang X, Guan Y, Zhao Z, Meng F, Wang X, Gao X, et al. Potential roles of the WNT signaling pathway in amyotrophic lateral sclerosis. Cells. 2021;10(4):839.","journal-title":"Cells"},{"issue":"9","key":"839_CR204","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.4103\/1673-5374.276320","volume":"15","author":"C Gonz\u00e1lez-Fern\u00e1ndez","year":"2020","unstructured":"Gonz\u00e1lez-Fern\u00e1ndez C, Gonz\u00e1lez P, Rodr\u00edguez FJ. New insights into Wnt signaling alterations in amyotrophic lateral sclerosis: a potential therapeutic target? Neural Regen Res. 2020;15(9):1580\u20139.","journal-title":"Neural Regen Res"},{"issue":"8","key":"839_CR205","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3390\/biomedicines9080969","volume":"9","author":"T Sahana","year":"2021","unstructured":"Sahana T, Zhang K. Mitogen-activated protein kinase pathway in amyotrophic lateral sclerosis. Biomedicines. 2021;9(8):969.","journal-title":"Biomedicines"},{"issue":"7\u20138","key":"839_CR206","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2021.151179","volume":"100","author":"R Sahu","year":"2021","unstructured":"Sahu R, Upadhayay S, Mehan S. Inhibition of extracellular regulated kinase (ERK)-1\/2 signaling pathway in the prevention of ALS: target inhibitors and influences on neurological dysfunctions. Eur J Cell Biol. 2021;100(7\u20138): 151179.","journal-title":"Eur J Cell Biol"},{"issue":"6","key":"839_CR207","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/j.1471-4159.2012.07871.x","volume":"122","author":"J Xiao","year":"2012","unstructured":"Xiao J, Ferner AH, Wong AW, Denham M, Kilpatrick TJ, Murray SS. Extracellular signal-regulated kinase 1\/2 signaling promotes oligodendrocyte myelination in vitro. J Neurochem. 2012;122(6):1167\u201380.","journal-title":"J Neurochem"},{"issue":"35","key":"839_CR208","doi-asserted-by":"publisher","first-page":"9186","DOI":"10.1523\/JNEUROSCI.1444-16.2016","volume":"36","author":"MA Jeffries","year":"2016","unstructured":"Jeffries MA, Urbanek K, Torres L, Wendell SG, Rubio ME, Fyffe-Maricich SL. ERK1\/2 activation in preexisting oligodendrocytes of adult mice drives new myelin synthesis and enhanced CNS function. J Neurosci. 2016;36(35):9186\u2013200.","journal-title":"J Neurosci"},{"key":"839_CR209","doi-asserted-by":"crossref","unstructured":"Suo N, Guo Ye, He B, Gu H, Xie X. Inhibition of MAPK\/ERK pathway promotes oligodendrocytes generation and recovery of demyelinating diseases. Glia. 2019;67(7):1320\u201332.","DOI":"10.1002\/glia.23606"},{"issue":"3","key":"839_CR210","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3390\/cells10030565","volume":"10","author":"S Raffaele","year":"2021","unstructured":"Raffaele S, Boccazzi M, Fumagalli M. Oligodendrocyte dysfunction in amyotrophic lateral sclerosis: mechanisms and therapeutic perspectives. Cells. 2021;10(3):565.","journal-title":"Cells"},{"issue":"8","key":"839_CR211","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.3390\/ijms22083875","volume":"22","author":"E K\u00e4llstig","year":"2021","unstructured":"K\u00e4llstig E, McCabe BD, Schneider BL. The Links between ALS and NF-\u03baB. Int J Mol Sci. 2021;22(8):3875.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"839_CR212","first-page":"449","volume":"2","author":"JS Tilstra","year":"2011","unstructured":"Tilstra JS, Clauson CL, Niedernhofer LJ, Robbins PD. NF-\u03baB in aging and disease. Aging Dis. 2011;2(6):449.","journal-title":"Aging Dis"},{"issue":"4","key":"839_CR213","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.celrep.2017.04.007","volume":"19","author":"I Kounatidis","year":"2017","unstructured":"Kounatidis I, Chtarbanova S, Cao Y, Hayne M, Jayanth D, Ganetzky B, et al. NF-\u03baB immunity in the brain determines fly lifespan in healthy aging and age-related neurodegeneration. Cell Rep. 2017;19(4):836\u201348.","journal-title":"Cell Rep"},{"key":"839_CR214","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2018.11.017","volume":"21","author":"F Sivandzade","year":"2019","unstructured":"Sivandzade F, Prasad S, Bhalerao A, Cucullo L. NRF2 and NF-\u049bB interplay in cerebrovascular and neurodegenerative disorders: molecular mechanisms and possible therapeutic approaches. Redox Biol. 2019;21: 101059.","journal-title":"Redox Biol"},{"issue":"10","key":"839_CR215","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140248","volume":"10","author":"AS Correia","year":"2015","unstructured":"Correia AS, Patel P, Dutta K, Julien J-P. Inflammation induces TDP-43 mislocalization and aggregation. PLoS ONE. 2015;10(10): e0140248.","journal-title":"PLoS ONE"},{"issue":"12","key":"839_CR216","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1084\/jem.20111313","volume":"208","author":"V Swarup","year":"2011","unstructured":"Swarup V, Phaneuf D, Dupr\u00e9 N, Petri S, Strong M, Kriz J, et al. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor \u03baB\u2013mediated pathogenic pathways. J Exp Med. 2011;208(12):2429\u201347.","journal-title":"J Exp Med"},{"key":"839_CR217","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.expneurol.2015.07.019","volume":"273","author":"W Zhao","year":"2015","unstructured":"Zhao W, Beers DR, Bell S, Wang J, Wen S, Baloh RH, et al. TDP-43 activates microglia through NF-\u03baB and NLRP3 inflammasome. Exp Neurol. 2015;273:24\u201335.","journal-title":"Exp Neurol"},{"issue":"11","key":"839_CR218","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142296","volume":"10","author":"J Zhu","year":"2015","unstructured":"Zhu J, Cynader MS, Jia W. TDP-43 inhibits NF-\u03baB activity by blocking p65 nuclear translocation. PLoS ONE. 2015;10(11): e0142296.","journal-title":"PLoS ONE"},{"issue":"26","key":"839_CR219","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1523\/JNEUROSCI.0536-20.2020","volume":"40","author":"K Dutta","year":"2020","unstructured":"Dutta K, Thammisetty SS, Boutej H, Bareil C, Julien J-P. Mitigation of ALS pathology by neuron-specific inhibition of nuclear factor kappa B signaling. J Neurosci. 2020;40(26):5137\u201354.","journal-title":"J Neurosci"},{"issue":"1","key":"839_CR220","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.cr.7290257","volume":"15","author":"T Zarubin","year":"2005","unstructured":"Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 2005;15(1):11\u20138.","journal-title":"Cell Res"},{"issue":"6","key":"839_CR221","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/0092-8674(94)90277-1","volume":"78","author":"J Rouse","year":"1994","unstructured":"Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, et al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 1994;78(6):1027\u201337.","journal-title":"Cell"},{"issue":"6","key":"839_CR222","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1074\/jbc.272.6.3296","volume":"272","author":"IN Foltz","year":"1997","unstructured":"Foltz IN, Lee JC, Young PR, Schrader JW. Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway. J Biol Chem. 1997;272(6):3296\u2013301.","journal-title":"J Biol Chem"},{"key":"839_CR223","doi-asserted-by":"crossref","unstructured":"Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E, et al. Phosphorylation of human p53 by p38 kinase coordinates N\u2010terminal phosphorylation and apoptosis in response to UV radiation. The EMBO journal. 1999.","DOI":"10.1093\/emboj\/18.23.6845"},{"issue":"4","key":"839_CR224","doi-asserted-by":"publisher","first-page":"N67","DOI":"10.1097\/00003246-200004001-00008","volume":"28","author":"T Obata","year":"2000","unstructured":"Obata T, Brown GE, Yaffe MB. MAP kinase pathways activated by stress: the p38 MAPK pathway. Crit Care Med. 2000;28(4):N67\u201377.","journal-title":"Crit Care Med"},{"issue":"4","key":"839_CR225","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1078\/S0171-9335(04)70027-8","volume":"79","author":"L Behrend","year":"2000","unstructured":"Behrend L, St\u00f6ter M, Kurth M, Rutter G, Heukeshoven J, Deppert W, et al. Interaction of casein kinase 1 delta (CK1\u03b4) with post-Golgi structures, microtubules and the spindle apparatus. Eur J Cell Biol. 2000;79(4):240\u201351.","journal-title":"Eur J Cell Biol"},{"issue":"5","key":"839_CR226","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1083\/jcb.201412075","volume":"210","author":"T Watanabe","year":"2015","unstructured":"Watanabe T, Kakeno M, Matsui T, Sugiyama I, Arimura N, Matsuzawa K, et al. TTBK2 with EB1\/3 regulates microtubule dynamics in migrating cells through KIF2A phosphorylation. J Cell Biol. 2015;210(5):737\u201351.","journal-title":"J Cell Biol"},{"key":"839_CR227","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10571-020-00875-6","volume":"41","author":"C Bao","year":"2021","unstructured":"Bao C, Bajrami B, Marcotte DJ, Chodaparambil JV, Kerns HM, Henderson J, et al. Mechanisms of regulation and diverse activities of tau-tubulin kinase (TTBK) isoforms. Cell Mol Neurobiol. 2021;41:669\u201385.","journal-title":"Cell Mol Neurobiol"},{"issue":"5","key":"839_CR228","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3390\/cancers14051345","volume":"14","author":"A Roth","year":"2022","unstructured":"Roth A, Gihring A, Bischof J, Pan L, Oswald F, Knippschild U. CK1 is a druggable regulator of microtubule dynamics and microtubule-associated processes. Cancers. 2022;14(5):1345.","journal-title":"Cancers"},{"key":"839_CR229","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fncel.2016.00204","volume":"10","author":"JA Clark","year":"2016","unstructured":"Clark JA, Yeaman EJ, Blizzard CA, Chuckowree JA, Dickson TC. A case for microtubule vulnerability in amyotrophic lateral sclerosis: altered dynamics during disease. Front Cell Neurosci. 2016;10:204.","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"839_CR230","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/dneu.20818","volume":"71","author":"PW Baas","year":"2011","unstructured":"Baas PW, Lin S. Hooks and comets: the story of microtubule polarity orientation in the neuron. Dev Neurobiol. 2011;71(6):403\u201318.","journal-title":"Dev Neurobiol"},{"issue":"7","key":"839_CR231","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.130061","volume":"3","author":"A Sakakibara","year":"2013","unstructured":"Sakakibara A, Ando R, Sapir T, Tanaka T. Microtubule dynamics in neuronal morphogenesis. Open Biol. 2013;3(7): 130061.","journal-title":"Open Biol"},{"issue":"12","key":"839_CR232","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.1073\/pnas.0506806103","volume":"103","author":"BL Chen","year":"2006","unstructured":"Chen BL, Hall DH, Chklovskii DB. Wiring optimization can relate neuronal structure and function. Proc Natl Acad Sci. 2006;103(12):4723\u20138.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"839_CR233","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.neuron.2004.07.022","volume":"43","author":"Y Kanai","year":"2004","unstructured":"Kanai Y, Dohmae N, Hirokawa N. Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. Neuron. 2004;43(4):513\u201325.","journal-title":"Neuron"},{"key":"839_CR234","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.648636","volume":"12","author":"H-Z Long","year":"2021","unstructured":"Long H-Z, Cheng Y, Zhou Z-W, Luo H-Y, Wen D-D, Gao L-C. PI3K\/AKT signal pathway: a target of natural products in the prevention and treatment of Alzheimer\u2019s disease and Parkinson\u2019s disease. Front Pharmacol. 2021;12: 648636.","journal-title":"Front Pharmacol"},{"issue":"8","key":"839_CR235","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023414","volume":"6","author":"L Ojeda","year":"2011","unstructured":"Ojeda L, Gao J, Hooten KG, Wang E, Thonhoff JR, Dunn TJ, et al. Critical role of PI3K\/Akt\/GSK3\u03b2 in motoneuron specification from human neural stem cells in response to FGF2 and EGF. PLoS ONE. 2011;6(8): e23414.","journal-title":"PLoS ONE"},{"issue":"6","key":"839_CR236","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/sj.cdd.4401604","volume":"12","author":"G Di Maira","year":"2005","unstructured":"Di Maira G, Salvi M, Arrigoni G, Marin O, Sarno S, Brustolon F, et al. Protein kinase CK2 phosphorylates and upregulates Akt\/PKB. Cell Death Differ. 2005;12(6):668\u201377.","journal-title":"Cell Death Differ"},{"key":"839_CR237","doi-asserted-by":"crossref","unstructured":"Girardi C, James P, Zanin S, Pinna LA, Ruzzene M. Differential phosphorylation of Akt1 and Akt2 by protein kinase CK2 may account for isoform specific functions. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2014;1843(9):1865\u201374.","DOI":"10.1016\/j.bbamcr.2014.04.020"},{"issue":"2","key":"839_CR238","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1074\/jbc.M009134200","volume":"276","author":"J Torres","year":"2001","unstructured":"Torres J, Pulido R. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus: implications for PTEN stability to proteasome-mediated degradation. J Biol Chem. 2001;276(2):993\u20138.","journal-title":"J Biol Chem"},{"issue":"1\u20133","key":"839_CR239","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0014-5793(02)03274-X","volume":"528","author":"SJ Miller","year":"2002","unstructured":"Miller SJ, Lou DY, Seldin DC, Lane WS, Neel BG. Direct identification of PTEN phosphorylation sites. FEBS Lett. 2002;528(1\u20133):145\u201353.","journal-title":"FEBS Lett"},{"issue":"4","key":"839_CR240","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/1758834014530023","volume":"6","author":"E Paplomata","year":"2014","unstructured":"Paplomata E, O\u2019Regan R. The PI3K\/AKT\/mTOR pathway in breast cancer: targets, trials and biomarkers. Therapeutic advances in medical oncology. 2014;6(4):154\u201366.","journal-title":"Therapeutic advances in medical oncology"},{"key":"839_CR241","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1007\/s00432-018-2737-y","volume":"144","author":"ML Gasparri","year":"2018","unstructured":"Gasparri ML, Besharat ZM, Farooqi AA, Khalid S, Taghavi K, Besharat RA, et al. MiRNAs and their interplay with PI3K\/AKT\/mTOR pathway in ovarian cancer cells: a potential role in platinum resistance. J Cancer Res Clin Oncol. 2018;144:2313\u20138.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"20","key":"839_CR242","doi-asserted-by":"publisher","first-page":"9454","DOI":"10.1073\/pnas.89.20.9454","volume":"89","author":"JL Brockman","year":"1992","unstructured":"Brockman JL, Gross SD, Sussman MR, Anderson RA. Cell cycle-dependent localization of casein kinase I to mitotic spindles. Proc Natl Acad Sci. 1992;89(20):9454\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"839_CR243","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.698661","volume":"9","author":"S Nandakumar","year":"2021","unstructured":"Nandakumar S, Rozich E, Buttitta L. Cell cycle re-entry in the nervous system: from polyploidy to neurodegeneration. Frontiers in Cell and Developmental Biology. 2021;9: 698661.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"8","key":"839_CR244","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1523\/JNEUROSCI.21-08-02661.2001","volume":"21","author":"Y Yang","year":"2001","unstructured":"Yang Y, Geldmacher DS, Herrup K. DNA replication precedes neuronal cell death in Alzheimer\u2019s disease. J Neurosci. 2001;21(8):2661\u20138.","journal-title":"J Neurosci"},{"issue":"7","key":"839_CR245","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1523\/JNEUROSCI.23-07-02557.2003","volume":"23","author":"Y Yang","year":"2003","unstructured":"Yang Y, Mufson EJ, Herrup K. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer\u2019s disease. J Neurosci. 2003;23(7):2557\u201363.","journal-title":"J Neurosci"},{"issue":"1","key":"839_CR246","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-180874","volume":"67","author":"MM Koseoglu","year":"2019","unstructured":"Koseoglu MM, Norambuena A, Sharlow ER, Lazo JS, Bloom GS. Aberrant neuronal cell cycle re-entry: The pathological confluence of Alzheimer\u2019s disease and brain insulin resistance, and its relation to cancer. J Alzheimers Dis. 2019;67(1):1\u201311.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"839_CR247","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0002-9440(10)63879-5","volume":"162","author":"S Ranganathan","year":"2003","unstructured":"Ranganathan S, Bowser R. Alterations in G1 to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am J Pathol. 2003;162(3):823\u201335.","journal-title":"Am J Pathol"},{"key":"839_CR248","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1874375701004010011","volume":"4","author":"S Ranganathan","year":"2010","unstructured":"Ranganathan S, Bowser R. p53 and cell cycle proteins participate in spinal motor neuron cell death in ALS. The open pathology journal. 2010;4:11.","journal-title":"The open pathology journal"},{"issue":"8","key":"839_CR249","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.tibs.2010.03.002","volume":"35","author":"M Bollen","year":"2010","unstructured":"Bollen M, Peti W, Ragusa MJ, Beullens M. The extended PP1 toolkit: designed to create specificity. Trends Biochem Sci. 2010;35(8):450\u20138.","journal-title":"Trends Biochem Sci"},{"issue":"18","key":"839_CR250","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1093\/emboj\/16.18.5537","volume":"16","author":"R Tournebize","year":"1997","unstructured":"Tournebize R, Andersen SS, Verde F, Dor\u00e9e M, Karsenti E, Hyman AA. Distinct roles of PP1 and PP2A-like phosphatases in control of microtubule dynamics during mitosis. Embo j. 1997;16(18):5537\u201349.","journal-title":"Embo j"},{"issue":"45","key":"839_CR251","doi-asserted-by":"publisher","first-page":"35034","DOI":"10.1074\/jbc.M005541200","volume":"275","author":"NM Fong","year":"2000","unstructured":"Fong NM, Jensen TC, Shah AS, Parekh NN, Saltiel AR, Brady MJ. Identification of Binding Sites on Protein Targeting to Glycogen for Enzymes of Glycogen Metabolism*. J Biol Chem. 2000;275(45):35034\u20139.","journal-title":"J Biol Chem"},{"issue":"6","key":"839_CR252","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S0896-6273(01)00554-2","volume":"32","author":"W Morishita","year":"2001","unstructured":"Morishita W, Connor JH, Xia H, Quinlan EM, Shenolikar S, Malenka RC. Regulation of synaptic strength by protein phosphatase 1. Neuron. 2001;32(6):1133\u201348.","journal-title":"Neuron"},{"issue":"5","key":"839_CR253","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.molcel.2009.02.015","volume":"33","author":"DM Virshup","year":"2009","unstructured":"Virshup DM, Shenolikar S. From promiscuity to precision: protein phosphatases get a makeover. Mol Cell. 2009;33(5):537\u201345.","journal-title":"Mol Cell"},{"issue":"3","key":"839_CR254","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/1873-3468.12976","volume":"592","author":"J Gu","year":"2018","unstructured":"Gu J, Wang W, Miao S, Chen F, Wu F, Hu W, et al. Protein Phosphatase 1 dephosphorylates TDP-43 and suppresses its function in tau exon 10 inclusion. FEBS Lett. 2018;592(3):402\u201310.","journal-title":"FEBS Lett"},{"issue":"1","key":"839_CR255","doi-asserted-by":"publisher","first-page":"48","DOI":"10.15252\/emmm.201708202","volume":"10","author":"ME Umoh","year":"2018","unstructured":"Umoh ME, Dammer EB, Dai J, Duong DM, Lah JJ, Levey AI, et al. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain. EMBO Mol Med. 2018;10(1):48\u201362.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"839_CR256","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2013.02.036","volume":"335","author":"P Seshacharyulu","year":"2013","unstructured":"Seshacharyulu P, Pandey P, Datta K, Batra SK. Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer. Cancer Lett. 2013;335(1):9\u201318.","journal-title":"Cancer Lett"},{"issue":"4","key":"839_CR257","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1152\/physrev.2000.80.4.1483","volume":"80","author":"F Rusnak","year":"2000","unstructured":"Rusnak F, Mertz P. Calcineurin: form and function. Physiol Rev. 2000;80(4):1483\u2013521.","journal-title":"Physiol Rev"},{"issue":"11","key":"839_CR258","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0166-2236(00)01930-5","volume":"24","author":"MA Cousin","year":"2001","unstructured":"Cousin MA, Robinson PJ. The dephosphins: dephosphorylation by calcineurin triggers synaptic vesicle endocytosis. Trends Neurosci. 2001;24(11):659\u201365.","journal-title":"Trends Neurosci"},{"key":"839_CR259","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1134\/S0006297918060056","volume":"83","author":"E Tarasova","year":"2018","unstructured":"Tarasova E, Gaydukov A, Balezina O. Calcineurin and its role in synaptic transmission. Biochem Mosc. 2018;83:674\u201389.","journal-title":"Biochem Mosc"},{"issue":"5","key":"839_CR260","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/j.1471-4159.2004.02588.x","volume":"90","author":"A Ferri","year":"2004","unstructured":"Ferri A, Nencini M, Battistini S, Giannini F, Siciliano G, Casali C, et al. Activity of protein phosphatase calcineurin is decreased in sporadic and familial amyotrophic lateral sclerosispatients. J Neurochem. 2004;90(5):1237\u201342.","journal-title":"J Neurochem"},{"issue":"5","key":"839_CR261","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1006\/nbdi.1997.0145","volume":"4","author":"R Wagey","year":"1997","unstructured":"Wagey R, Krieger C, Shaw CA. Abnormal dephosphorylation effect on NMDA receptor regulation in ALS spinal cord. Neurobiol Dis. 1997;4(5):350\u20135.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"839_CR262","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neuron.2019.01.048","volume":"102","author":"JR Mann","year":"2019","unstructured":"Mann JR, Gleixner AM, Mauna JC, Gomes E, DeChellis-Marks MR, Needham PG, et al. RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43. Neuron. 2019;102(2):321-38.e8.","journal-title":"Neuron"},{"key":"839_CR263","doi-asserted-by":"crossref","unstructured":"Zhang P, Fan B, Yang P, Temirov J, Messing J, Kim HJ, et al. Chronic optogenetic induction of stress granules is cytotoxic and reveals the evolution of ALS-FTD pathology. Elife. 2019;8.","DOI":"10.7554\/eLife.39578"},{"key":"839_CR264","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00401-015-1460-x","volume":"130","author":"AK Walker","year":"2015","unstructured":"Walker AK, Spiller KJ, Ge G, Zheng A, Xu Y, Zhou M, et al. Functional recovery in new mouse models of ALS\/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol. 2015;130:643\u201360.","journal-title":"Acta Neuropathol"},{"issue":"23","key":"839_CR265","doi-asserted-by":"publisher","first-page":"7802","DOI":"10.1523\/JNEUROSCI.0172-14.2014","volume":"34","author":"Q Deng","year":"2014","unstructured":"Deng Q, Holler CJ, Taylor G, Hudson KF, Watkins W, Gearing M, et al. FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage. J Neurosci. 2014;34(23):7802\u201313.","journal-title":"J Neurosci"},{"issue":"2","key":"839_CR266","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1471-4159.2010.07098.x","volume":"116","author":"OA Brady","year":"2011","unstructured":"Brady OA, Meng P, Zheng Y, Mao Y, Hu F. Regulation of TDP-43 aggregation by phosphorylation andp62\/SQSTM1. J Neurochem. 2011;116(2):248\u201359.","journal-title":"J Neurochem"},{"issue":"2","key":"839_CR267","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, et al. \u03b1-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol. 2002;4(2):160\u20134.","journal-title":"Nat Cell Biol"},{"issue":"40","key":"839_CR268","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson JP, Walker DE, Goldstein JM, De Laat R, Banducci K, Caccavello RJ, et al. Phosphorylation of Ser-129 is the dominant pathological modification of \u03b1-synuclein in familial and sporadic Lewy body disease. J Biol Chem. 2006;281(40):29739\u201352.","journal-title":"J Biol Chem"},{"issue":"2","key":"839_CR269","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/BJ20081135","volume":"415","author":"M Gardiner","year":"2008","unstructured":"Gardiner M, Toth R, Vandermoere F, Morrice NA, Rouse J. Identification and characterization of FUS\/TLS as a new target of ATM. Biochemical Journal. 2008;415(2):297\u2013307.","journal-title":"Biochemical Journal"},{"issue":"15","key":"839_CR270","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1091\/mbc.E17-12-0735","volume":"29","author":"SN Rhoads","year":"2018","unstructured":"Rhoads SN, Monahan ZT, Yee DS, Leung AY, Newcombe CG, O\u2019Meally RN, et al. The prionlike domain of FUS is multiphosphorylated following DNA damage without altering nuclear localization. Mol Biol Cell. 2018;29(15):1786\u201397.","journal-title":"Mol Biol Cell"},{"issue":"3","key":"839_CR271","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","volume":"15","author":"DP Hanger","year":"2009","unstructured":"Hanger DP, Anderton BH, Noble W. Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med. 2009;15(3):112\u20139.","journal-title":"Trends Mol Med"},{"issue":"1","key":"839_CR272","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-00480-0","volume":"8","author":"S Ambadipudi","year":"2017","unstructured":"Ambadipudi S, Biernat J, Riedel D, Mandelkow E, Zweckstetter M. Liquid\u2013liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein Tau. Nat Commun. 2017;8(1):1\u201313.","journal-title":"Nat Commun"},{"issue":"1","key":"839_CR273","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-16580-3","volume":"11","author":"NM Kanaan","year":"2020","unstructured":"Kanaan NM, Hamel C, Grabinski T, Combs B. Liquid-liquid phase separation induces pathogenic tau conformations in vitro. Nat Commun. 2020;11(1):1\u201316.","journal-title":"Nat Commun"},{"issue":"8","key":"839_CR274","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41557-020-0465-9","volume":"12","author":"S Ray","year":"2020","unstructured":"Ray S, Singh N, Kumar R, Patel K, Pandey S, Datta D, et al. \u03b1-Synuclein aggregation nucleates through liquid\u2013liquid phase separation. Nat Chem. 2020;12(8):705\u201316.","journal-title":"Nat Chem"},{"issue":"20","key":"839_CR275","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.15252\/embj.201696394","volume":"36","author":"Z Monahan","year":"2017","unstructured":"Monahan Z, Ryan VH, Janke AM, Burke KA, Rhoads SN, Zerze GH, et al. Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity. Embo j. 2017;36(20):2951\u201367.","journal-title":"Embo j"},{"issue":"4","key":"839_CR276","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41594-020-0399-3","volume":"27","author":"Z Liu","year":"2020","unstructured":"Liu Z, Zhang S, Gu J, Tong Y, Li Y, Gui X, et al. Hsp27 chaperones FUS phase separation under the modulation of stress-induced phosphorylation. Nat Struct Mol Biol. 2020;27(4):363\u201372.","journal-title":"Nat Struct Mol Biol"},{"key":"839_CR277","doi-asserted-by":"crossref","unstructured":"Kishino Y, Matsukawa K, Matsumoto T, Miyazaki R, Wakabayashi T, Nonaka T, et al. Casein kinase 1\u03b4\/\u03b5 phosphorylates fused in sarcoma (FUS) and ameliorates FUS-mediated neurodegeneration. Journal of Biological Chemistry. 2022;298(8).","DOI":"10.1016\/j.jbc.2022.102191"},{"issue":"3","key":"839_CR278","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1046\/j.1471-4159.1995.64031420.x","volume":"64","author":"TJ Singh","year":"1995","unstructured":"Singh TJ, Grundke-Iqbal I, Iqbal K. Phosphorylation of \u03c4 Protein by Casein Kinase-1 Converts It to an Abnormal Alzheimer-Like State. J Neurochem. 1995;64(3):1420\u20133.","journal-title":"J Neurochem"},{"key":"839_CR279","doi-asserted-by":"publisher","first-page":"1243277","DOI":"10.3389\/fnmol.2023.1243277","volume":"16","author":"L Martinez-Gonzalez","year":"2023","unstructured":"Martinez-Gonzalez L, Cuevas EP, Tosat Bitrian C, Nozal V, Gil C, Palomo V, et al. TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer\u2019s disease patients. Front Mol Neurosci. 2023;16:1243277.","journal-title":"Front Mol Neurosci"},{"key":"839_CR280","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cbpa.2015.07.001","volume":"28","author":"Z Chen","year":"2015","unstructured":"Chen Z, Cole PA. Synthetic approaches to protein phosphorylation. Curr Opin Chem Biol. 2015;28:115\u201322.","journal-title":"Curr Opin Chem Biol"},{"issue":"8","key":"839_CR281","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1172\/JCI85456","volume":"126","author":"S Brahmachari","year":"2016","unstructured":"Brahmachari S, Ge P, Lee SH, Kim D, Karuppagounder SS, Kumar M, et al. Activation of tyrosine kinase c-Abl contributes to \u03b1-synuclein\u2013induced neurodegeneration. J Clin Investig. 2016;126(8):2970\u201388.","journal-title":"J Clin Investig"},{"issue":"11","key":"839_CR282","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1093\/hmg\/ddt674","volume":"23","author":"A-L Mahul-Mellier","year":"2014","unstructured":"Mahul-Mellier A-L, Fauvet B, Gysbers A, Dikiy I, Oueslati A, Georgeon S, et al. c-Abl phosphorylates \u03b1-synuclein and regulates its degradation: implication for \u03b1-synuclein clearance and contribution to the pathogenesis of Parkinson\u2019s disease. Hum Mol Genet. 2014;23(11):2858\u201379.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"839_CR283","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1523\/JNEUROSCI.1833-10.2011","volume":"31","author":"SZ Imam","year":"2011","unstructured":"Imam SZ, Zhou Q, Yamamoto A, Valente AJ, Ali SF, Bains M, et al. Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson\u2019s disease. J Neurosci. 2011;31(1):157\u201363.","journal-title":"J Neurosci"},{"issue":"28","key":"839_CR284","doi-asserted-by":"publisher","first-page":"6584","DOI":"10.1523\/JNEUROSCI.1487-05.2005","volume":"25","author":"P Derkinderen","year":"2005","unstructured":"Derkinderen P, Scales TM, Hanger DP, Leung K-Y, Byers HL, Ward MA, et al. Tyrosine 394 is phosphorylated in Alzheimer\u2019s paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase. J Neurosci. 2005;25(28):6584\u201393.","journal-title":"J Neurosci"},{"issue":"2","key":"839_CR285","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3233\/JAD-2010-1271","volume":"19","author":"MA Tremblay","year":"2010","unstructured":"Tremblay MA, Acker CM, Davies P. Tau phosphorylated at tyrosine 394 is found in Alzheimer\u2019s disease tangles and can be a product of the Abl-related kinase. Arg Journal of Alzheimer\u2019s Disease. 2010;19(2):721\u201333.","journal-title":"Arg Journal of Alzheimer's Disease"},{"issue":"2","key":"839_CR286","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.molbrainres.2005.04.015","volume":"138","author":"IE Vega","year":"2005","unstructured":"Vega IE, Cui L, Propst JA, Hutton ML, Lee G, Yen SH. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates. Brain Res Mol Brain Res. 2005;138(2):135\u201344.","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"839_CR287","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/bpa.12775","volume":"30","author":"J Gu","year":"2020","unstructured":"Gu J, Hu W, Tan X, Qu S, Chu D, Gong CX, et al. Elevation of casein kinase 1\u03b5 associated with TDP-43 and tau pathologies in Alzheimer\u2019s disease. Brain Pathol. 2020;30(2):283\u201397.","journal-title":"Brain Pathol"},{"issue":"10","key":"839_CR288","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1073\/pnas.0611236104","volume":"104","author":"M Flajolet","year":"2007","unstructured":"Flajolet M, He G, Heiman M, Lin A, Nairn AC, Greengard P. Regulation of Alzheimer\u2019s disease amyloid-\u03b2 formation by casein kinase I. Proc Natl Acad Sci. 2007;104(10):4159\u201364.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"839_CR289","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0006-8993(90)90282-G","volume":"507","author":"DS Iimoto","year":"1990","unstructured":"Iimoto DS, Masliah E, DeTeresa R, Terry RD, Saitoh T. Aberrant casein kinase II in Alzheimer\u2019s disease. Brain Res. 1990;507(2):273\u201380.","journal-title":"Brain Res"},{"key":"839_CR290","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-015-0470-x","volume":"13","author":"AF Rosenberger","year":"2016","unstructured":"Rosenberger AF, Morrema TH, Gerritsen WH, van Haastert ES, Snkhchyan H, Hilhorst R, et al. Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer\u2019s disease pathology. J Neuroinflammation. 2016;13:1\u201314.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"839_CR291","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1242\/jcs.01655","volume":"118","author":"C Feijoo","year":"2005","unstructured":"Feijoo C, Campbell DG, Jakes R, Goedert M, Cuenda A. Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4\/p38\u03b4 at Thr50 promotes microtubule assembly. J Cell Sci. 2005;118(2):397\u2013408.","journal-title":"J Cell Sci"},{"issue":"1","key":"839_CR292","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/0014-5793(94)80247-5","volume":"341","author":"C-X Gong","year":"1994","unstructured":"Gong C-X, Grundke-Iqbal I, Damuni Z, Iqbal K. Dephosphorylation of microtubule-associated protein tau by protein phosphatase-1 and-2C and its implication in Alzheimer disease. FEBS Lett. 1994;341(1):94\u20138.","journal-title":"FEBS Lett"},{"issue":"3","key":"839_CR293","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1471-4159.1993.tb03603.x","volume":"61","author":"CX Gong","year":"1993","unstructured":"Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K. Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem. 1993;61(3):921\u20137.","journal-title":"J Neurochem"},{"issue":"2","key":"839_CR294","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1046\/j.1471-4159.1995.65020732.x","volume":"65","author":"CX Gong","year":"1995","unstructured":"Gong CX, Shaikh S, Wang JZ, Zaidi T, Grundke-Iqbal I, Iqbal K. Phosphatase activity toward abnormally phosphorylated \u03c4: decrease in Alzheimer disease brain. J Neurochem. 1995;65(2):732\u20138.","journal-title":"J Neurochem"},{"issue":"19","key":"839_CR295","doi-asserted-by":"publisher","first-page":"6963","DOI":"10.1523\/JNEUROSCI.6513-10.2011","volume":"31","author":"K-W Lee","year":"2011","unstructured":"Lee K-W, Chen W, Junn E, Im J-Y, Grosso H, Sonsalla PK, et al. Enhanced phosphatase activity attenuates \u03b1-synucleinopathy in a mouse model. J Neurosci. 2011;31(19):6963\u201371.","journal-title":"J Neurosci"},{"key":"839_CR296","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Revuelta B, Hettich M, Ciociaro A, Rotermund C, Kahle P, Krauss S, et al. Metformin lowers Ser-129 phosphorylated \u03b1-synuclein levels via mTOR-dependent protein phosphatase 2A activation. Cell Death Dis. 2014;5(5):e1209-e.","DOI":"10.1038\/cddis.2014.175"},{"issue":"8","key":"839_CR297","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1074\/jbc.275.8.5535","volume":"275","author":"C-X Gong","year":"2000","unstructured":"Gong C-X, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, Iqbal K. Phosphorylation of Microtubule-associated Protein Tau Is Regulated by Protein Phosphatase 2A in Mammalian Brain: implications for neurofibrillary degeneration in alzheimer\u2019s disease*. J Biol Chem. 2000;275(8):5535\u201344.","journal-title":"J Biol Chem"},{"issue":"3","key":"839_CR298","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0014-5793(93)80850-T","volume":"336","author":"G Drewes","year":"1993","unstructured":"Drewes G, Mandelkow E-M, Baumann K, Goris J, Merlevede W, Mandelkow E. Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcmeurin and phosphatase-2A. FEBS Lett. 1993;336(3):425\u201332.","journal-title":"FEBS Lett"},{"issue":"4","key":"839_CR299","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/0306-4522(94)90400-6","volume":"61","author":"C-X Gong","year":"1994","unstructured":"Gong C-X, Grundke-Iqbal I, Iqbal K. Dephosphorylation of Alzheimer\u2019s disease abnormally phosphorylated tau by protein phosphatase-2A. Neuroscience. 1994;61(4):765\u201372.","journal-title":"Neuroscience"},{"issue":"6","key":"839_CR300","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1046\/j.1471-4159.1995.65062804.x","volume":"65","author":"M Goedert","year":"1995","unstructured":"Goedert M, Jakes R, Qi Z, Wang J, Cohen P. Protein Phosphatase 2A Is the Major Enzyme in Brain that Dephosphorylates \u03c4 Protein Phosphorylated by Proline-Directed Protein Kinases or Cyclic AMP-Dependent Protein Kinase. J Neurochem. 1995;65(6):2804\u20137.","journal-title":"J Neurochem"},{"issue":"9","key":"839_CR301","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1074\/jbc.270.9.4854","volume":"270","author":"J-Z Wang","year":"1995","unstructured":"Wang J-Z, Gong C-X, Zaidi T, Grundke-Iqbal I, Iqbal K. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and\u2212 2B. J Biol Chem. 1995;270(9):4854\u201360.","journal-title":"J Biol Chem"},{"issue":"6","key":"839_CR302","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/S0896-6273(00)80250-0","volume":"17","author":"E Sontag","year":"1996","unstructured":"Sontag E, Nunbhakdi-Craig V, Lee G, Bloom GS, Mumby MC. Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A. Neuron. 1996;17(6):1201\u20137.","journal-title":"Neuron"},{"key":"839_CR303","doi-asserted-by":"crossref","unstructured":"Vogelsberg-Ragaglia V, Schuck T, Trojanowski JQ, Lee VM-Y. PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Experimental neurology. 2001;168(2):402\u201312.","DOI":"10.1006\/exnr.2001.7630"},{"issue":"4","key":"839_CR304","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/jnen\/63.4.287","volume":"63","author":"E Sontag","year":"2004","unstructured":"Sontag E, Luangpirom A, Hladik C, Mudrak I, Ogris E, Speciale S, et al. Altered Expression Levels of the Protein Phosphatase 2A AB\u03b1C Enzyme Are Associated with Alzheimer Disease Pathology. J Neuropathol Exp Neurol. 2004;63(4):287\u2013301.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"839_CR305","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1046\/j.1471-4159.1994.62020803.x","volume":"62","author":"CX Gong","year":"1994","unstructured":"Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K. Alzheimer\u2019s Disease Abnormally Phosphorylated \u03c4 Is Dephosphorylated by Protein Phosphatase-2B (Calcineurin). J Neurochem. 1994;62(2):803\u20136.","journal-title":"J Neurochem"},{"key":"839_CR306","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00702-005-0313-5","volume":"113","author":"A Rahman","year":"2006","unstructured":"Rahman A, Grundke-Iqbal I, Iqbal K. PP2B isolated from human brain preferentially dephosphorylates Ser-262 and Ser-396 of the Alzheimer disease abnormally hyperphosphorylated tau. J Neural Transm. 2006;113:219\u201330.","journal-title":"J Neural Transm"},{"issue":"1","key":"839_CR307","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1006\/exnr.2000.7534","volume":"167","author":"Q Lian","year":"2001","unstructured":"Lian Q, Ladner CJ, Magnuson D, Lee JM. Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer\u2019s disease cerebral cortex. Exp Neurol. 2001;167(1):158\u201365.","journal-title":"Exp Neurol"},{"issue":"8","key":"839_CR308","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1097\/00005072-199608000-00008","volume":"55","author":"CJ Ladner","year":"1996","unstructured":"Ladner CJ, Czech J, Maurice J, Lorens SA, Lee JM. Reduction of Calcineurin Enzymatic Activity in Alzheimer\u2019s Disease: Correlation with Neuropathologic Changes. J Neuropathol Exp Neurol. 1996;55(8):924\u201331.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"839_CR309","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3233\/JAD-2010-100987","volume":"23","author":"W Qian","year":"2011","unstructured":"Qian W, Yin X, Hu W, Shi J, Gu J, Grundke-Iqbal I, et al. Activation of protein phosphatase 2B and hyperphosphorylation of Tau in Alzheimer\u2019s disease. J Alzheimers Dis. 2011;23(4):617\u201327.","journal-title":"J Alzheimers Dis"},{"issue":"48","key":"839_CR310","doi-asserted-by":"publisher","first-page":"16208","DOI":"10.1523\/JNEUROSCI.2911-10.2010","volume":"30","author":"NF Liachko","year":"2010","unstructured":"Liachko NF, Guthrie CR, Kraemer BC. Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy. J Neurosci. 2010;30(48):16208\u201319.","journal-title":"J Neurosci"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00839-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00839-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00839-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T13:03:58Z","timestamp":1746709438000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-025-00839-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":310,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1186\/s13024-025-00839-8","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}